<corpus id="HPRD50">
  <document id="HPRD50.d0" origId="10373544">
    <sentence id="HPRD50.d0.s0" origId="10373544.1.1" text="Cloning and characterization of two evolutionarily conserved subunits (_________ and ________) of human ______ and their involvement in functional interactions with TFIIIB and RNA polymerase III">
      <entity charOffset="71-79" id="HPRD50.d0.s0.e0" origId="10" type="pm0125479" />
      <entity charOffset="85-92" id="HPRD50.d0.s0.e1" origId="12" type="pm0100174" />
      <entity charOffset="104-109" id="HPRD50.d0.s0.e2" origId="16" type="pm0120026" />
      <pair e1="HPRD50.d0.s0.e0" e2="HPRD50.d0.s0.e1" id="HPRD50.d0.s0.p0" interaction="False" />
      <pair e1="HPRD50.d0.s0.e0" e2="HPRD50.d0.s0.e2" id="HPRD50.d0.s0.p1" interaction="False" />
      <pair e1="HPRD50.d0.s0.e1" e2="HPRD50.d0.s0.e2" id="HPRD50.d0.s0.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d1" origId="10529171">
    <sentence id="HPRD50.d1.s0" origId="10529171.1.1" text="Identification of residues in the ______________________________ that contact the MCP-1 receptor, ____">
      <entity charOffset="34-63" id="HPRD50.d1.s0.e0" origId="8" type="pm0117207" />
      <entity charOffset="98-101" id="HPRD50.d1.s0.e1" origId="15" type="pm0111607" />
      <pair e1="HPRD50.d1.s0.e0" e2="HPRD50.d1.s0.e1" id="HPRD50.d1.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d1.s1" origId="10529171.2.12" text="The receptor binding site of _____ also is significantly different from the binding sites of ______ and ____, providing insight into the issue of receptor specificity">
      <entity charOffset="29-33" id="HPRD50.d1.s1.e0" origId="6" type="pm0111607||pm0117207||pm0124628" />
      <entity charOffset="93-98" id="HPRD50.d1.s1.e1" origId="16" type="pm0105763" />
      <entity charOffset="104-107" id="HPRD50.d1.s1.e2" origId="18" type="pm0121149" />
      <pair e1="HPRD50.d1.s1.e0" e2="HPRD50.d1.s1.e1" id="HPRD50.d1.s1.p0" interaction="False" />
      <pair e1="HPRD50.d1.s1.e0" e2="HPRD50.d1.s1.e2" id="HPRD50.d1.s1.p1" interaction="False" />
      <pair e1="HPRD50.d1.s1.e1" e2="HPRD50.d1.s1.e2" id="HPRD50.d1.s1.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d1.s2" origId="10529171.2.13" text="It was previously shown that the N-terminus of ____ is critical for binding _____">
      <entity charOffset="47-50" id="HPRD50.d1.s2.e0" origId="9" type="pm0111607" />
      <entity charOffset="76-80" id="HPRD50.d1.s2.e1" origId="14" type="pm0111607||pm0117207||pm0124628" />
      <pair e1="HPRD50.d1.s2.e0" e2="HPRD50.d1.s2.e1" id="HPRD50.d1.s2.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d1.s3" origId="10529171.2.2" text="To identify the regions of _____ that contact its receptor, ____, we substituted all surface-exposed residues with alanine">
      <entity charOffset="27-31" id="HPRD50.d1.s3.e0" origId="6" type="pm0111607||pm0117207||pm0124628" />
      <entity charOffset="60-63" id="HPRD50.d1.s3.e1" origId="12" type="pm0111607" />
      <pair e1="HPRD50.d1.s3.e0" e2="HPRD50.d1.s3.e1" id="HPRD50.d1.s3.p0" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d2" origId="10563789">
    <sentence id="HPRD50.d2.s0" origId="10563789.2.10" text="We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the _______ subunit or the _____________ and ________ monomer">
      <entity charOffset="94-100" id="HPRD50.d2.s0.e0" origId="19" type="pm0125097" />
      <entity charOffset="117-129" id="HPRD50.d2.s0.e1" origId="25" type="pm0125097" />
      <entity charOffset="135-142" id="HPRD50.d2.s0.e2" origId="28" type="pm0104723" />
      <pair e1="HPRD50.d2.s0.e0" e2="HPRD50.d2.s0.e1" id="HPRD50.d2.s0.p0" interaction="False" />
      <pair e1="HPRD50.d2.s0.e0" e2="HPRD50.d2.s0.e2" id="HPRD50.d2.s0.p1" interaction="False" />
      <pair e1="HPRD50.d2.s0.e1" e2="HPRD50.d2.s0.e2" id="HPRD50.d2.s0.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d2.s1" origId="10563789.2.17" text="The formation of a functional single chain/subunit complex was not restricted to the FSH single chain/_______ subunit since CG single chain interacts with the monomeric ________ subunit and exhibits FSH activity">
      <entity charOffset="102-108" id="HPRD50.d2.s1.e0" origId="21" type="pm0125097" />
      <entity charOffset="169-176" id="HPRD50.d2.s1.e1" origId="32" type="pm0104723" />
      <pair e1="HPRD50.d2.s1.e0" e2="HPRD50.d2.s1.e1" id="HPRD50.d2.s1.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d2.s2" origId="10563789.2.5" text="This is relevant for the case of LH and FSH, because both are synthesized in the same cell (i.e., pituitary gonadotrophs) and several of the alpha subunit sequences required for association with either the _______ or ________ subunits are different">
      <entity charOffset="206-212" id="HPRD50.d2.s2.e0" origId="41" type="pm0117290" />
      <entity charOffset="217-224" id="HPRD50.d2.s2.e1" origId="44" type="pm0104723" />
      <pair e1="HPRD50.d2.s2.e0" e2="HPRD50.d2.s2.e1" id="HPRD50.d2.s2.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d2.s3" origId="10563789.2.7" text="Previously, we showed that the _______ or ________ subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, _____________ and F beta alpha, respectively">
      <entity charOffset="31-37" id="HPRD50.d2.s3.e0" origId="8" type="pm0125097" />
      <entity charOffset="42-49" id="HPRD50.d2.s3.e1" origId="11" type="pm0104723" />
      <entity charOffset="154-166" id="HPRD50.d2.s3.e2" origId="31" type="pm0125097" />
      <pair e1="HPRD50.d2.s3.e0" e2="HPRD50.d2.s3.e1" id="HPRD50.d2.s3.p0" interaction="False" />
      <pair e1="HPRD50.d2.s3.e0" e2="HPRD50.d2.s3.e2" id="HPRD50.d2.s3.p1" interaction="False" />
      <pair e1="HPRD50.d2.s3.e1" e2="HPRD50.d2.s3.e2" id="HPRD50.d2.s3.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d3" origId="10579793">
    <sentence id="HPRD50.d3.s0" origId="10579793.1.1" text="_____________ activates _____________________________, which inhibits apoptosis in human prostate cancer cell lines">
      <entity charOffset="0-12" id="HPRD50.d3.s0.e0" origId="1" type="pm0110911" />
      <entity charOffset="24-52" id="HPRD50.d3.s0.e1" origId="4" type="pm0104655||pm0110290||pm0120114||pm0122783||pm0124741" />
      <pair e1="HPRD50.d3.s0.e0" e2="HPRD50.d3.s0.e1" id="HPRD50.d3.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d3.s1" origId="10579793.2.6" text="RESULTS: Tyrosine phosphorylation of p85 is upregulated by ____ in both LNCaP and ____">
      <entity charOffset="59-62" id="HPRD50.d3.s1.e0" origId="10" type="pm0110911" />
      <entity charOffset="82-85" id="HPRD50.d3.s1.e1" origId="15" type="pm0107379||pm0107715||pm0114827" />
      <pair e1="HPRD50.d3.s1.e0" e2="HPRD50.d3.s1.e1" id="HPRD50.d3.s1.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d3.s2" origId="10579793.2.7" text="____ promotes coprecipitation of p85 with _____, the signal-transducing component of the _____________">
      <entity charOffset="0-3" id="HPRD50.d3.s2.e0" origId="1" type="pm0110911" />
      <entity charOffset="42-46" id="HPRD50.d3.s2.e1" origId="7" type="pm0113266||pm0122272" />
      <entity charOffset="89-101" id="HPRD50.d3.s2.e2" origId="15" type="pm0106299" />
      <pair e1="HPRD50.d3.s2.e0" e2="HPRD50.d3.s2.e1" id="HPRD50.d3.s2.p0" interaction="True" />
      <pair e1="HPRD50.d3.s2.e0" e2="HPRD50.d3.s2.e2" id="HPRD50.d3.s2.p1" interaction="False" />
      <pair e1="HPRD50.d3.s2.e1" e2="HPRD50.d3.s2.e2" id="HPRD50.d3.s2.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d4" origId="10736564">
    <sentence id="HPRD50.d4.s0" origId="10736564.2.5" text="In solution, FGFR4ed formed complexes with __________________ and _________________, both in the presence and absence of heparin">
      <entity charOffset="43-60" id="HPRD50.d4.s0.e0" origId="12" type="pm0124654" />
      <entity charOffset="66-82" id="HPRD50.d4.s0.e1" origId="18" type="pm0106166" />
      <pair e1="HPRD50.d4.s0.e0" e2="HPRD50.d4.s0.e1" id="HPRD50.d4.s0.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d4.s1" origId="10736564.2.6" text="Immobilized _____ also bound _____ besides _____ and _____">
      <entity charOffset="12-16" id="HPRD50.d4.s1.e0" origId="2" type="pm0119069" />
      <entity charOffset="29-33" id="HPRD50.d4.s1.e1" origId="5" type="pm0118903" />
      <entity charOffset="43-47" id="HPRD50.d4.s1.e2" origId="7" type="pm0124654" />
      <entity charOffset="53-57" id="HPRD50.d4.s1.e3" origId="9" type="pm0106166" />
      <pair e1="HPRD50.d4.s1.e0" e2="HPRD50.d4.s1.e1" id="HPRD50.d4.s1.p0" interaction="True" />
      <pair e1="HPRD50.d4.s1.e0" e2="HPRD50.d4.s1.e2" id="HPRD50.d4.s1.p1" interaction="True" />
      <pair e1="HPRD50.d4.s1.e0" e2="HPRD50.d4.s1.e3" id="HPRD50.d4.s1.p2" interaction="True" />
      <pair e1="HPRD50.d4.s1.e1" e2="HPRD50.d4.s1.e2" id="HPRD50.d4.s1.p3" interaction="False" />
      <pair e1="HPRD50.d4.s1.e1" e2="HPRD50.d4.s1.e3" id="HPRD50.d4.s1.p4" interaction="False" />
      <pair e1="HPRD50.d4.s1.e2" e2="HPRD50.d4.s1.e3" id="HPRD50.d4.s1.p5" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d5" origId="10835351">
    <sentence id="HPRD50.d5.s0" origId="10835351.1.1" text="___________ regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with _____">
      <entity charOffset="0-10" id="HPRD50.d5.s0.e0" origId="1" type="pm0124251" />
      <entity charOffset="107-111" id="HPRD50.d5.s0.e1" origId="13" type="pm0104657||pm0114514" />
      <pair e1="HPRD50.d5.s0.e0" e2="HPRD50.d5.s0.e1" id="HPRD50.d5.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d5.s1" origId="10835351.2.2" text="Here we provide evidence of how ___________, an integrin-binding protein and guanine-nucleotide exchange factor (GEF) for ___ GTPases, regulates cell adhesion">
      <entity charOffset="32-42" id="HPRD50.d5.s1.e0" origId="7" type="pm0124251" />
      <entity charOffset="122-124" id="HPRD50.d5.s1.e1" origId="20" type="pm0126206" />
      <pair e1="HPRD50.d5.s1.e0" e2="HPRD50.d5.s1.e1" id="HPRD50.d5.s1.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d5.s2" origId="10835351.2.3" text="Mutational analyses of the beta-2 cytoplasmic domain revealed that the adhesive function of _____ depends on its interaction with ___________, unless the integrin is activated by exogenous divalent cations">
      <entity charOffset="92-96" id="HPRD50.d5.s2.e0" origId="14" type="pm0104657||pm0114514" />
      <entity charOffset="130-140" id="HPRD50.d5.s2.e1" origId="20" type="pm0124251" />
      <pair e1="HPRD50.d5.s2.e0" e2="HPRD50.d5.s2.e1" id="HPRD50.d5.s2.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d5.s3" origId="10835351.2.4" text="Secondly, ___________ induces expression of an extracellular activation epitope of _____, and the exchange factor function is not essential for this activity">
      <entity charOffset="10-20" id="HPRD50.d5.s3.e0" origId="3" type="pm0124251" />
      <entity charOffset="83-87" id="HPRD50.d5.s3.e1" origId="12" type="pm0104657||pm0114514" />
      <pair e1="HPRD50.d5.s3.e0" e2="HPRD50.d5.s3.e1" id="HPRD50.d5.s3.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d5.s4" origId="10835351.2.5" text="In contrast, LFA-1-mediated cell adhesion and spreading on intercellular cell adhesion molecule 1 is strongly inhibited by a ___________ mutant, which fails to catalyze ___ GDP-GTP exchange in vitro">
      <entity charOffset="125-135" id="HPRD50.d5.s4.e0" origId="20" type="pm0124251" />
      <entity charOffset="169-171" id="HPRD50.d5.s4.e1" origId="27" type="pm0126206" />
      <pair e1="HPRD50.d5.s4.e0" e2="HPRD50.d5.s4.e1" id="HPRD50.d5.s4.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d5.s5" origId="10835351.2.6" text="Thus, ___________ is involved in the activation of _____, most probably through direct interaction with the integrin, and induces cell spreading by its ARF-GEF activity">
      <entity charOffset="6-16" id="HPRD50.d5.s5.e0" origId="3" type="pm0124251" />
      <entity charOffset="51-55" id="HPRD50.d5.s5.e1" origId="10" type="pm0104657||pm0114514" />
      <pair e1="HPRD50.d5.s5.e0" e2="HPRD50.d5.s5.e1" id="HPRD50.d5.s5.p0" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d7" origId="10930400">
    <sentence id="HPRD50.d7.s0" origId="10930400.1.1" text="Suppression of rat thromboxane synthase gene transcription by ________________________________________________ in macrophages via an interaction with ____">
      <entity charOffset="62-109" id="HPRD50.d7.s0.e0" origId="12" type="pm0103183" />
      <entity charOffset="150-153" id="HPRD50.d7.s0.e1" origId="19" type="pm0105918||pm0123857" />
      <pair e1="HPRD50.d7.s0.e0" e2="HPRD50.d7.s0.e1" id="HPRD50.d7.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d7.s1" origId="10930400.2.5" text="Deletion analysis showed that the element responsible for the PPARgamma effect is located in a region containing the nuclear factor E2 (_____)/____ site (-98/-88), which was indicated to be the major promoter of the TXS gene">
      <entity charOffset="136-140" id="HPRD50.d7.s1.e0" origId="23" type="pm0120477" />
      <entity charOffset="143-146" id="HPRD50.d7.s1.e1" origId="26" type="pm0103880" />
      <pair e1="HPRD50.d7.s1.e0" e2="HPRD50.d7.s1.e1" id="HPRD50.d7.s1.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d7.s2" origId="10930400.2.6" text="By electrophoretic mobility shift assay using the _____/____ site and nuclear extracts from macrophages, we observed a specific protein-DNA complex formation, which was inhibited by a specific antibody against the transcription factor ____ (______________________)">
      <entity charOffset="50-54" id="HPRD50.d7.s2.e0" origId="8" type="pm0120477" />
      <entity charOffset="56-59" id="HPRD50.d7.s2.e1" origId="10" type="pm0103880" />
      <entity charOffset="235-238" id="HPRD50.d7.s2.e2" origId="37" type="pm0105918||pm0123857" />
      <entity charOffset="241-262" id="HPRD50.d7.s2.e3" origId="41" type="pm0105918" />
      <pair e1="HPRD50.d7.s2.e0" e2="HPRD50.d7.s2.e1" id="HPRD50.d7.s2.p0" interaction="False" />
      <pair e1="HPRD50.d7.s2.e0" e2="HPRD50.d7.s2.e2" id="HPRD50.d7.s2.p1" interaction="False" />
      <pair e1="HPRD50.d7.s2.e0" e2="HPRD50.d7.s2.e3" id="HPRD50.d7.s2.p2" interaction="False" />
      <pair e1="HPRD50.d7.s2.e1" e2="HPRD50.d7.s2.e2" id="HPRD50.d7.s2.p3" interaction="False" />
      <pair e1="HPRD50.d7.s2.e1" e2="HPRD50.d7.s2.e3" id="HPRD50.d7.s2.p4" interaction="False" />
      <pair e1="HPRD50.d7.s2.e2" e2="HPRD50.d7.s2.e3" id="HPRD50.d7.s2.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d7.s3" origId="10930400.2.9" text="Finally, a direct interaction between PPARgamma and ____ was confirmed by _________________________ pull-down assay">
      <entity charOffset="52-55" id="HPRD50.d7.s3.e0" origId="9" type="pm0105918||pm0123857" />
      <entity charOffset="74-98" id="HPRD50.d7.s3.e1" origId="14" type="pm0116848" />
      <pair e1="HPRD50.d7.s3.e0" e2="HPRD50.d7.s3.e1" id="HPRD50.d7.s3.p0" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d8" origId="10995457">
    <sentence id="HPRD50.d8.s0" origId="10995457.2.3" text="By constructing deletion mutants, we identified that amino acid residues 229-309 of Akt were involved in the binding to _____ and amino acid residues 327-340 of _________ were involved in the binding to Akt">
      <entity charOffset="120-124" id="HPRD50.d8.s0.e0" origId="21" type="pm0114253||pm0121838" />
      <entity charOffset="161-169" id="HPRD50.d8.s0.e1" origId="28" type="pm0121838" />
      <pair e1="HPRD50.d8.s0.e0" e2="HPRD50.d8.s0.e1" id="HPRD50.d8.s0.p0" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d9" origId="11171101">
    <sentence id="HPRD50.d9.s0" origId="11171101.2.2" text="Here, we cloned and characterized a mouse orthologue of human ________ protein as an atypical ___ (named ________)">
      <entity charOffset="62-69" id="HPRD50.d9.s0.e0" origId="12" type="pm0110335" />
      <entity charOffset="94-96" id="HPRD50.d9.s0.e1" origId="17" type="pm0109470||pm0116152" />
      <entity charOffset="105-112" id="HPRD50.d9.s0.e2" origId="21" type="pm0110335" />
      <pair e1="HPRD50.d9.s0.e0" e2="HPRD50.d9.s0.e1" id="HPRD50.d9.s0.p0" interaction="False" />
      <pair e1="HPRD50.d9.s0.e0" e2="HPRD50.d9.s0.e2" id="HPRD50.d9.s0.p1" interaction="False" />
      <pair e1="HPRD50.d9.s0.e1" e2="HPRD50.d9.s0.e2" id="HPRD50.d9.s0.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d9.s1" origId="11171101.2.3" text="Subcellular fractionation and antibody-uptake experiments indicate that ________ is indeed a type-I membrane protein, but, unlike other ___ isoforms, lacks an N-terminal extracellular domain">
      <entity charOffset="72-79" id="HPRD50.d9.s1.e0" origId="9" type="pm0110335" />
      <entity charOffset="136-138" id="HPRD50.d9.s1.e1" origId="21" type="pm0109470||pm0116152" />
      <pair e1="HPRD50.d9.s1.e0" e2="HPRD50.d9.s1.e1" id="HPRD50.d9.s1.p0" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d11" origId="11313349">
    <sentence id="HPRD50.d11.s0" origId="11313349.1.1" text="Direct interaction between the cytoplasmic tail of _______ and the Src homology 3 domain of ________ activates _____________________________ in C2C12 cells">
      <entity charOffset="51-57" id="HPRD50.d11.s0.e0" origId="9" type="pm0118647" />
      <entity charOffset="92-99" id="HPRD50.d11.s0.e1" origId="17" type="pm0124741" />
      <entity charOffset="111-139" id="HPRD50.d11.s0.e2" origId="20" type="pm0104655||pm0110290||pm0120114||pm0122783||pm0124741" />
      <pair e1="HPRD50.d11.s0.e0" e2="HPRD50.d11.s0.e1" id="HPRD50.d11.s0.p0" interaction="True" />
      <pair e1="HPRD50.d11.s0.e0" e2="HPRD50.d11.s0.e2" id="HPRD50.d11.s0.p1" interaction="True" />
      <pair e1="HPRD50.d11.s0.e1" e2="HPRD50.d11.s0.e2" id="HPRD50.d11.s0.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d11.s1" origId="11313349.2.5" text="This suggests that transmembrane _______, by providing docking sites for the Src homology 3 domain of ________, activates PI 3-kinase by mediating its recruitment to the membrane">
      <entity charOffset="33-39" id="HPRD50.d11.s1.e0" origId="6" type="pm0118647" />
      <entity charOffset="102-109" id="HPRD50.d11.s1.e1" origId="19" type="pm0124741" />
      <pair e1="HPRD50.d11.s1.e0" e2="HPRD50.d11.s1.e1" id="HPRD50.d11.s1.p0" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d12" origId="11779129">
    <sentence id="HPRD50.d12.s0" origId="11779129.1.1" text="_____ binds to the C-terminal SH2 domain of ______________________ and inhibits its enzymatic activity">
      <entity charOffset="0-4" id="HPRD50.d12.s0.e0" origId="1" type="pm0106306" />
      <entity charOffset="44-65" id="HPRD50.d12.s0.e1" origId="10" type="pm0126499" />
      <pair e1="HPRD50.d12.s0.e0" e2="HPRD50.d12.s0.e1" id="HPRD50.d12.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d12.s1" origId="11779129.2.4" text="In this report, we demonstrate the stable association of _________ with _____ in a clathrin-coated vesicle complex, which not only binds to the carboxyl-terminal SH2 domain of _________, but also inhibits its enzymatic activity in a dose-dependent manner">
      <entity charOffset="57-65" id="HPRD50.d12.s1.e0" origId="11" type="pm0126499" />
      <entity charOffset="72-76" id="HPRD50.d12.s1.e1" origId="13" type="pm0106306" />
      <entity charOffset="176-184" id="HPRD50.d12.s1.e2" origId="30" type="pm0126499" />
      <pair e1="HPRD50.d12.s1.e0" e2="HPRD50.d12.s1.e1" id="HPRD50.d12.s1.p0" interaction="True" />
      <pair e1="HPRD50.d12.s1.e0" e2="HPRD50.d12.s1.e2" id="HPRD50.d12.s1.p1" interaction="False" />
      <pair e1="HPRD50.d12.s1.e1" e2="HPRD50.d12.s1.e2" id="HPRD50.d12.s1.p2" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d13" origId="11940666">
    <sentence id="HPRD50.d13.s0" origId="11940666.2.5" text="Here we demonstrate colocalization and direct interaction between ________ and ____">
      <entity charOffset="66-73" id="HPRD50.d13.s0.e0" origId="9" type="pm0124985" />
      <entity charOffset="79-82" id="HPRD50.d13.s0.e1" origId="11" type="pm0110467" />
      <pair e1="HPRD50.d13.s0.e0" e2="HPRD50.d13.s0.e1" id="HPRD50.d13.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d13.s1" origId="11940666.2.7" text="Overexpression of ________ results in a zinc finger-dependent localization of a ____________ isoform and dynactin to MT bundles, raising the possibility that ________ and ____ regulate dynein/dynactin binding to MTs">
      <entity charOffset="18-25" id="HPRD50.d13.s1.e0" origId="3" type="pm0124985" />
      <entity charOffset="80-91" id="HPRD50.d13.s1.e1" origId="12" type="phospho-pm0110467" />
      <entity charOffset="158-165" id="HPRD50.d13.s1.e2" origId="24" type="pm0124985" />
      <entity charOffset="171-174" id="HPRD50.d13.s1.e3" origId="26" type="pm0110467" />
      <pair e1="HPRD50.d13.s1.e0" e2="HPRD50.d13.s1.e1" id="HPRD50.d13.s1.p0" interaction="True" />
      <pair e1="HPRD50.d13.s1.e0" e2="HPRD50.d13.s1.e2" id="HPRD50.d13.s1.p1" interaction="False" />
      <pair e1="HPRD50.d13.s1.e0" e2="HPRD50.d13.s1.e3" id="HPRD50.d13.s1.p2" interaction="False" />
      <pair e1="HPRD50.d13.s1.e1" e2="HPRD50.d13.s1.e2" id="HPRD50.d13.s1.p3" interaction="False" />
      <pair e1="HPRD50.d13.s1.e1" e2="HPRD50.d13.s1.e3" id="HPRD50.d13.s1.p4" interaction="False" />
      <pair e1="HPRD50.d13.s1.e2" e2="HPRD50.d13.s1.e3" id="HPRD50.d13.s1.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d13.s2" origId="11940666.2.8" text="This work suggests that ____ is a regulated adapter between ________ and cytoplasmic dynein at sites involved in cargo-MT loading, and/or in the control of MT dynamics">
      <entity charOffset="24-27" id="HPRD50.d13.s2.e0" origId="5" type="pm0110467" />
      <entity charOffset="60-67" id="HPRD50.d13.s2.e1" origId="11" type="pm0124985" />
      <pair e1="HPRD50.d13.s2.e0" e2="HPRD50.d13.s2.e1" id="HPRD50.d13.s2.p0" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d14" origId="11994745">
    <sentence id="HPRD50.d14.s0" origId="11994745.1.1" text="_______ and _______: multifunctional endocytic receptors">
      <entity charOffset="0-6" id="HPRD50.d14.s0.e0" origId="1" type="pm0100604" />
      <entity charOffset="12-18" id="HPRD50.d14.s0.e1" origId="3" type="pm0100963" />
      <pair e1="HPRD50.d14.s0.e0" e2="HPRD50.d14.s0.e1" id="HPRD50.d14.s0.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d14.s1" origId="11994745.2.2" text="_______ and _______ are two structurally different endocytic receptors that interact to serve such functions">
      <entity charOffset="0-6" id="HPRD50.d14.s1.e0" origId="1" type="pm0100604" />
      <entity charOffset="12-18" id="HPRD50.d14.s1.e1" origId="3" type="pm0100963" />
      <pair e1="HPRD50.d14.s1.e0" e2="HPRD50.d14.s1.e1" id="HPRD50.d14.s1.p0" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d16" origId="12124778">
    <sentence id="HPRD50.d16.s0" origId="12124778.1.1" text="_______ and _______ are ____/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress">
      <entity charOffset="0-6" id="HPRD50.d16.s0.e0" origId="1" type="pm0114403" />
      <entity charOffset="12-18" id="HPRD50.d16.s0.e1" origId="3" type="pm0116690" />
      <entity charOffset="24-27" id="HPRD50.d16.s0.e2" origId="5" type="pm0113152" />
      <pair e1="HPRD50.d16.s0.e0" e2="HPRD50.d16.s0.e1" id="HPRD50.d16.s0.p0" interaction="False" />
      <pair e1="HPRD50.d16.s0.e0" e2="HPRD50.d16.s0.e2" id="HPRD50.d16.s0.p1" interaction="True" />
      <pair e1="HPRD50.d16.s0.e1" e2="HPRD50.d16.s0.e2" id="HPRD50.d16.s0.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d16.s1" origId="12124778.2.1" text="_______ (______), _______ (______), and _______ (___) constitute a family of evolutionarily conserved, small, acidic, nuclear proteins, which have been implicated in terminal differentiation, growth suppression, and apoptosis">
      <entity charOffset="0-6" id="HPRD50.d16.s1.e0" origId="1" type="pm0112301" />
      <entity charOffset="9-14" id="HPRD50.d16.s1.e1" origId="3" type="pm0112301" />
      <entity charOffset="18-24" id="HPRD50.d16.s1.e2" origId="6" type="pm0114403" />
      <entity charOffset="27-32" id="HPRD50.d16.s1.e3" origId="8" type="pm0114403" />
      <entity charOffset="40-46" id="HPRD50.d16.s1.e4" origId="12" type="pm0116690" />
      <entity charOffset="49-51" id="HPRD50.d16.s1.e5" origId="14" type="pm0102392||pm0116690" />
      <pair e1="HPRD50.d16.s1.e0" e2="HPRD50.d16.s1.e1" id="HPRD50.d16.s1.p0" interaction="False" />
      <pair e1="HPRD50.d16.s1.e0" e2="HPRD50.d16.s1.e2" id="HPRD50.d16.s1.p1" interaction="False" />
      <pair e1="HPRD50.d16.s1.e0" e2="HPRD50.d16.s1.e3" id="HPRD50.d16.s1.p2" interaction="False" />
      <pair e1="HPRD50.d16.s1.e0" e2="HPRD50.d16.s1.e4" id="HPRD50.d16.s1.p3" interaction="False" />
      <pair e1="HPRD50.d16.s1.e0" e2="HPRD50.d16.s1.e5" id="HPRD50.d16.s1.p4" interaction="False" />
      <pair e1="HPRD50.d16.s1.e1" e2="HPRD50.d16.s1.e2" id="HPRD50.d16.s1.p5" interaction="False" />
      <pair e1="HPRD50.d16.s1.e1" e2="HPRD50.d16.s1.e3" id="HPRD50.d16.s1.p6" interaction="False" />
      <pair e1="HPRD50.d16.s1.e1" e2="HPRD50.d16.s1.e4" id="HPRD50.d16.s1.p7" interaction="False" />
      <pair e1="HPRD50.d16.s1.e1" e2="HPRD50.d16.s1.e5" id="HPRD50.d16.s1.p8" interaction="False" />
      <pair e1="HPRD50.d16.s1.e2" e2="HPRD50.d16.s1.e3" id="HPRD50.d16.s1.p9" interaction="False" />
      <pair e1="HPRD50.d16.s1.e2" e2="HPRD50.d16.s1.e4" id="HPRD50.d16.s1.p10" interaction="False" />
      <pair e1="HPRD50.d16.s1.e2" e2="HPRD50.d16.s1.e5" id="HPRD50.d16.s1.p11" interaction="False" />
      <pair e1="HPRD50.d16.s1.e3" e2="HPRD50.d16.s1.e4" id="HPRD50.d16.s1.p12" interaction="False" />
      <pair e1="HPRD50.d16.s1.e3" e2="HPRD50.d16.s1.e5" id="HPRD50.d16.s1.p13" interaction="False" />
      <pair e1="HPRD50.d16.s1.e4" e2="HPRD50.d16.s1.e5" id="HPRD50.d16.s1.p14" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d16.s2" origId="12124778.2.3" text="Recent evidence has implicated _______ in inhibition of ____/cyclinB1 kinase and in G2/M cell cycle arrest">
      <entity charOffset="31-37" id="HPRD50.d16.s2.e0" origId="5" type="pm0112301" />
      <entity charOffset="56-59" id="HPRD50.d16.s2.e1" origId="9" type="pm0113152" />
      <pair e1="HPRD50.d16.s2.e0" e2="HPRD50.d16.s2.e1" id="HPRD50.d16.s2.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d16.s3" origId="12124778.2.4" text="Yet, whether _______ and/or _______ function as inhibitors of ____/cyclinB1 kinase and/or play a role in G2/M cell cycle arrest has not been fully established">
      <entity charOffset="13-19" id="HPRD50.d16.s3.e0" origId="4" type="pm0114403" />
      <entity charOffset="28-34" id="HPRD50.d16.s3.e1" origId="6" type="pm0116690" />
      <entity charOffset="62-65" id="HPRD50.d16.s3.e2" origId="11" type="pm0113152" />
      <pair e1="HPRD50.d16.s3.e0" e2="HPRD50.d16.s3.e1" id="HPRD50.d16.s3.p0" interaction="False" />
      <pair e1="HPRD50.d16.s3.e0" e2="HPRD50.d16.s3.e2" id="HPRD50.d16.s3.p1" interaction="True" />
      <pair e1="HPRD50.d16.s3.e1" e2="HPRD50.d16.s3.e2" id="HPRD50.d16.s3.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d16.s4" origId="12124778.2.5" text="In this work, we show that _______ and _______ specifically interact with the ____/CyclinB1 complex, but not with other Cdk/Cyclin complexes, in vitro and in vivo">
      <entity charOffset="27-33" id="HPRD50.d16.s4.e0" origId="8" type="pm0114403" />
      <entity charOffset="39-45" id="HPRD50.d16.s4.e1" origId="10" type="pm0116690" />
      <entity charOffset="78-81" id="HPRD50.d16.s4.e2" origId="15" type="pm0113152" />
      <pair e1="HPRD50.d16.s4.e0" e2="HPRD50.d16.s4.e1" id="HPRD50.d16.s4.p0" interaction="False" />
      <pair e1="HPRD50.d16.s4.e0" e2="HPRD50.d16.s4.e2" id="HPRD50.d16.s4.p1" interaction="True" />
      <pair e1="HPRD50.d16.s4.e1" e2="HPRD50.d16.s4.e2" id="HPRD50.d16.s4.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d16.s5" origId="12124778.2.6" text="Data also has been obtained that _______ and _______, as well as _______, interact with both ____ and cyclinB1, resulting in inhibition of the kinase activity of the ____/cyclinB1 complex">
      <entity charOffset="33-39" id="HPRD50.d16.s5.e0" origId="7" type="pm0114403" />
      <entity charOffset="45-51" id="HPRD50.d16.s5.e1" origId="9" type="pm0116690" />
      <entity charOffset="65-71" id="HPRD50.d16.s5.e2" origId="14" type="pm0112301" />
      <entity charOffset="93-96" id="HPRD50.d16.s5.e3" origId="19" type="pm0113152" />
      <entity charOffset="166-169" id="HPRD50.d16.s5.e4" origId="32" type="pm0113152" />
      <pair e1="HPRD50.d16.s5.e0" e2="HPRD50.d16.s5.e1" id="HPRD50.d16.s5.p0" interaction="False" />
      <pair e1="HPRD50.d16.s5.e0" e2="HPRD50.d16.s5.e2" id="HPRD50.d16.s5.p1" interaction="False" />
      <pair e1="HPRD50.d16.s5.e0" e2="HPRD50.d16.s5.e3" id="HPRD50.d16.s5.p2" interaction="True" />
      <pair e1="HPRD50.d16.s5.e0" e2="HPRD50.d16.s5.e4" id="HPRD50.d16.s5.p3" interaction="True" />
      <pair e1="HPRD50.d16.s5.e1" e2="HPRD50.d16.s5.e2" id="HPRD50.d16.s5.p4" interaction="False" />
      <pair e1="HPRD50.d16.s5.e1" e2="HPRD50.d16.s5.e3" id="HPRD50.d16.s5.p5" interaction="True" />
      <pair e1="HPRD50.d16.s5.e1" e2="HPRD50.d16.s5.e4" id="HPRD50.d16.s5.p6" interaction="True" />
      <pair e1="HPRD50.d16.s5.e2" e2="HPRD50.d16.s5.e3" id="HPRD50.d16.s5.p7" interaction="True" />
      <pair e1="HPRD50.d16.s5.e2" e2="HPRD50.d16.s5.e4" id="HPRD50.d16.s5.p8" interaction="True" />
      <pair e1="HPRD50.d16.s5.e3" e2="HPRD50.d16.s5.e4" id="HPRD50.d16.s5.p9" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d16.s6" origId="12124778.2.7" text="Inhibition of ____/cyclinB1 kinase activity by _______ and _______ was found to involve disruption of the complex, whereas _______ did not disrupt the complex">
      <entity charOffset="14-17" id="HPRD50.d16.s6.e0" origId="3" type="pm0113152" />
      <entity charOffset="47-53" id="HPRD50.d16.s6.e1" origId="9" type="pm0114403" />
      <entity charOffset="59-65" id="HPRD50.d16.s6.e2" origId="11" type="pm0112301" />
      <entity charOffset="123-129" id="HPRD50.d16.s6.e3" origId="22" type="pm0116690" />
      <pair e1="HPRD50.d16.s6.e0" e2="HPRD50.d16.s6.e1" id="HPRD50.d16.s6.p0" interaction="True" />
      <pair e1="HPRD50.d16.s6.e0" e2="HPRD50.d16.s6.e2" id="HPRD50.d16.s6.p1" interaction="True" />
      <pair e1="HPRD50.d16.s6.e0" e2="HPRD50.d16.s6.e3" id="HPRD50.d16.s6.p2" interaction="False" />
      <pair e1="HPRD50.d16.s6.e1" e2="HPRD50.d16.s6.e2" id="HPRD50.d16.s6.p3" interaction="False" />
      <pair e1="HPRD50.d16.s6.e1" e2="HPRD50.d16.s6.e3" id="HPRD50.d16.s6.p4" interaction="False" />
      <pair e1="HPRD50.d16.s6.e2" e2="HPRD50.d16.s6.e3" id="HPRD50.d16.s6.p5" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d18" origId="12370829">
    <sentence id="HPRD50.d18.s0" origId="12370829.1.1" text="The transmembrane _____________________________________ ____ interacts with _________">
      <entity charOffset="18-54" id="HPRD50.d18.s0.e0" origId="6" type="pm0104157" />
      <entity charOffset="56-59" id="HPRD50.d18.s0.e1" origId="7" type="pm0115917" />
      <entity charOffset="76-84" id="HPRD50.d18.s0.e2" origId="13" type="pm0101886" />
      <pair e1="HPRD50.d18.s0.e0" e2="HPRD50.d18.s0.e1" id="HPRD50.d18.s0.p0" interaction="False" />
      <pair e1="HPRD50.d18.s0.e0" e2="HPRD50.d18.s0.e2" id="HPRD50.d18.s0.p1" interaction="True" />
      <pair e1="HPRD50.d18.s0.e1" e2="HPRD50.d18.s0.e2" id="HPRD50.d18.s0.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d18.s1" origId="12370829.2.1" text="The __________________________________________ ____, also known as _____, is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes">
      <entity charOffset="4-45" id="HPRD50.d18.s1.e0" origId="5" type="pm0104157" />
      <entity charOffset="47-50" id="HPRD50.d18.s1.e1" origId="6" type="pm0115917" />
      <entity charOffset="67-71" id="HPRD50.d18.s1.e2" origId="11" type="pm0115917" />
      <pair e1="HPRD50.d18.s1.e0" e2="HPRD50.d18.s1.e1" id="HPRD50.d18.s1.p0" interaction="False" />
      <pair e1="HPRD50.d18.s1.e0" e2="HPRD50.d18.s1.e2" id="HPRD50.d18.s1.p1" interaction="False" />
      <pair e1="HPRD50.d18.s1.e1" e2="HPRD50.d18.s1.e2" id="HPRD50.d18.s1.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d18.s2" origId="12370829.2.5" text="____ also interacted with other members of the catenin gene family including ____________ and gamma-catenin">
      <entity charOffset="0-3" id="HPRD50.d18.s2.e0" origId="1" type="pm0115917" />
      <entity charOffset="77-88" id="HPRD50.d18.s2.e1" origId="13" type="pm0126674" />
      <pair e1="HPRD50.d18.s2.e0" e2="HPRD50.d18.s2.e1" id="HPRD50.d18.s2.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d18.s3" origId="12370829.2.6" text="The interaction with _________ is likely to be direct, as the interaction occurs in K562 cells lacking functional adherens junctions and __________ expression">
      <entity charOffset="21-29" id="HPRD50.d18.s3.e0" origId="7" type="pm0101886" />
      <entity charOffset="137-146" id="HPRD50.d18.s3.e1" origId="26" type="pm0115783" />
      <pair e1="HPRD50.d18.s3.e0" e2="HPRD50.d18.s3.e1" id="HPRD50.d18.s3.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d18.s4" origId="12370829.2.7" text="Catalytic domains of the tyrosine phosphatases ________, ____, and PTPbeta did not interact with proteins of the catenin family to detectable levels, suggesting that the interaction of ____ with these proteins is specific">
      <entity charOffset="47-54" id="HPRD50.d18.s4.e0" origId="7" type="pm0117107" />
      <entity charOffset="57-60" id="HPRD50.d18.s4.e1" origId="9" type="pm0110536" />
      <entity charOffset="185-188" id="HPRD50.d18.s4.e2" origId="31" type="pm0115917" />
      <pair e1="HPRD50.d18.s4.e0" e2="HPRD50.d18.s4.e1" id="HPRD50.d18.s4.p0" interaction="False" />
      <pair e1="HPRD50.d18.s4.e0" e2="HPRD50.d18.s4.e2" id="HPRD50.d18.s4.p1" interaction="False" />
      <pair e1="HPRD50.d18.s4.e1" e2="HPRD50.d18.s4.e2" id="HPRD50.d18.s4.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d19" origId="12371907">
    <sentence id="HPRD50.d19.s0" origId="12371907.1.1" text="____/_____________________________________ (&apos;____&apos;)-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (_____) and thyroid hormone receptor-retinoid X receptor">
      <entity charOffset="0-3" id="HPRD50.d19.s0.e0" origId="1" type="pm0126787" />
      <entity charOffset="5-41" id="HPRD50.d19.s0.e1" origId="3" type="pm0100874" />
      <entity charOffset="45-48" id="HPRD50.d19.s0.e2" origId="6" type="pm0100874" />
      <entity charOffset="133-137" id="HPRD50.d19.s0.e3" origId="22" type="pm0122391" />
      <pair e1="HPRD50.d19.s0.e0" e2="HPRD50.d19.s0.e1" id="HPRD50.d19.s0.p0" interaction="False" />
      <pair e1="HPRD50.d19.s0.e0" e2="HPRD50.d19.s0.e2" id="HPRD50.d19.s0.p1" interaction="False" />
      <pair e1="HPRD50.d19.s0.e0" e2="HPRD50.d19.s0.e3" id="HPRD50.d19.s0.p2" interaction="True" />
      <pair e1="HPRD50.d19.s0.e1" e2="HPRD50.d19.s0.e2" id="HPRD50.d19.s0.p3" interaction="False" />
      <pair e1="HPRD50.d19.s0.e1" e2="HPRD50.d19.s0.e3" id="HPRD50.d19.s0.p4" interaction="True" />
      <pair e1="HPRD50.d19.s0.e2" e2="HPRD50.d19.s0.e3" id="HPRD50.d19.s0.p5" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d19.s1" origId="12371907.2.3" text="____/_____________________________________ (&apos;____&apos;)-binding protein (CBP) interacting with transcription factors is able to increase their activity on target gene promoters">
      <entity charOffset="0-3" id="HPRD50.d19.s1.e0" origId="1" type="pm0126787" />
      <entity charOffset="5-41" id="HPRD50.d19.s1.e1" origId="3" type="pm0100874" />
      <entity charOffset="45-48" id="HPRD50.d19.s1.e2" origId="6" type="pm0100874" />
      <pair e1="HPRD50.d19.s1.e0" e2="HPRD50.d19.s1.e1" id="HPRD50.d19.s1.p0" interaction="False" />
      <pair e1="HPRD50.d19.s1.e0" e2="HPRD50.d19.s1.e2" id="HPRD50.d19.s1.p1" interaction="False" />
      <pair e1="HPRD50.d19.s1.e1" e2="HPRD50.d19.s1.e2" id="HPRD50.d19.s1.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d19.s2" origId="12371907.2.7" text="Our findings showed that the same C-terminal portion of ____ binds the N-terminal domains of both TR and _____, and our in vivo studies demonstrated that TR, _____ and ____ form a ternary complex">
      <entity charOffset="56-59" id="HPRD50.d19.s2.e0" origId="10" type="pm0126787" />
      <entity charOffset="105-109" id="HPRD50.d19.s2.e1" origId="19" type="pm0122391" />
      <entity charOffset="158-162" id="HPRD50.d19.s2.e2" origId="30" type="pm0122391" />
      <entity charOffset="168-171" id="HPRD50.d19.s2.e3" origId="32" type="pm0126787" />
      <pair e1="HPRD50.d19.s2.e0" e2="HPRD50.d19.s2.e1" id="HPRD50.d19.s2.p0" interaction="True" />
      <pair e1="HPRD50.d19.s2.e0" e2="HPRD50.d19.s2.e2" id="HPRD50.d19.s2.p1" interaction="False" />
      <pair e1="HPRD50.d19.s2.e0" e2="HPRD50.d19.s2.e3" id="HPRD50.d19.s2.p2" interaction="False" />
      <pair e1="HPRD50.d19.s2.e1" e2="HPRD50.d19.s2.e2" id="HPRD50.d19.s2.p3" interaction="False" />
      <pair e1="HPRD50.d19.s2.e1" e2="HPRD50.d19.s2.e3" id="HPRD50.d19.s2.p4" interaction="False" />
      <pair e1="HPRD50.d19.s2.e2" e2="HPRD50.d19.s2.e3" id="HPRD50.d19.s2.p5" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d20" origId="12655004">
    <sentence id="HPRD50.d20.s0" origId="12655004.1.1" text="The human ____ and ____ proteins form a ternary complex with hMpp10, which only interacts with the U3 ______ in 60-80S ribonucleoprotein complexes">
      <entity charOffset="10-13" id="HPRD50.d20.s0.e0" origId="3" type="pm0100548||pm0102353||pm0121765" />
      <entity charOffset="19-22" id="HPRD50.d20.s0.e1" origId="5" type="pm0104160||pm0117832" />
      <entity charOffset="102-107" id="HPRD50.d20.s0.e2" origId="20" type="pm0114346" />
      <pair e1="HPRD50.d20.s0.e0" e2="HPRD50.d20.s0.e1" id="HPRD50.d20.s0.p0" interaction="True" />
      <pair e1="HPRD50.d20.s0.e0" e2="HPRD50.d20.s0.e2" id="HPRD50.d20.s0.p1" interaction="True" />
      <pair e1="HPRD50.d20.s0.e1" e2="HPRD50.d20.s0.e2" id="HPRD50.d20.s0.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d20.s1" origId="12655004.2.3" text="We have cloned cDNAs encoding the human and mouse homologs of the yeast U3 snoRNP-associated proteins ____ and ____">
      <entity charOffset="102-105" id="HPRD50.d20.s1.e0" origId="17" type="pm0100548||pm0102353||pm0121765" />
      <entity charOffset="111-114" id="HPRD50.d20.s1.e1" origId="19" type="pm0104160||pm0117832" />
      <pair e1="HPRD50.d20.s1.e0" e2="HPRD50.d20.s1.e1" id="HPRD50.d20.s1.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d20.s2" origId="12655004.2.5" text="The results of complementation experiments show that, in contrast to mouse ____, mouse ____ can partially alleviate the growth defect of the corresponding yeast null strain, indicating that the role of ____ in pre-rRNA processing is evolutionarily conserved">
      <entity charOffset="75-78" id="HPRD50.d20.s2.e0" origId="13" type="pm0104160||pm0117832" />
      <entity charOffset="87-90" id="HPRD50.d20.s2.e1" origId="16" type="pm0100548||pm0102353||pm0121765" />
      <entity charOffset="202-205" id="HPRD50.d20.s2.e2" origId="35" type="pm0100548||pm0102353||pm0121765" />
      <pair e1="HPRD50.d20.s2.e0" e2="HPRD50.d20.s2.e1" id="HPRD50.d20.s2.p0" interaction="False" />
      <pair e1="HPRD50.d20.s2.e0" e2="HPRD50.d20.s2.e2" id="HPRD50.d20.s2.p1" interaction="False" />
      <pair e1="HPRD50.d20.s2.e1" e2="HPRD50.d20.s2.e2" id="HPRD50.d20.s2.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d20.s3" origId="12655004.2.6" text="The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human ____ and ____ proteins predominantly interact with the U3 ______ in 60-80S ribonucleoprotein complexes">
      <entity charOffset="104-107" id="HPRD50.d20.s3.e0" origId="18" type="pm0100548||pm0102353||pm0121765" />
      <entity charOffset="113-116" id="HPRD50.d20.s3.e1" origId="20" type="pm0104160||pm0117832" />
      <entity charOffset="162-167" id="HPRD50.d20.s3.e2" origId="27" type="pm0114346" />
      <pair e1="HPRD50.d20.s3.e0" e2="HPRD50.d20.s3.e1" id="HPRD50.d20.s3.p0" interaction="False" />
      <pair e1="HPRD50.d20.s3.e0" e2="HPRD50.d20.s3.e2" id="HPRD50.d20.s3.p1" interaction="True" />
      <pair e1="HPRD50.d20.s3.e1" e2="HPRD50.d20.s3.e2" id="HPRD50.d20.s3.p2" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d21" origId="12690115">
    <sentence id="HPRD50.d21.s0" origId="12690115.2.1" text="In the present study, we observed evidence of cross-talk between the cannabinoid receptor ___ and the _________________ (____) using a heterologous system">
      <entity charOffset="90-92" id="HPRD50.d21.s0.e0" origId="15" type="pm0109721" />
      <entity charOffset="102-118" id="HPRD50.d21.s0.e1" origId="20" type="pm0111533" />
      <entity charOffset="121-124" id="HPRD50.d21.s0.e2" origId="22" type="pm0111533" />
      <pair e1="HPRD50.d21.s0.e0" e2="HPRD50.d21.s0.e1" id="HPRD50.d21.s0.p0" interaction="True" />
      <pair e1="HPRD50.d21.s0.e0" e2="HPRD50.d21.s0.e2" id="HPRD50.d21.s0.p1" interaction="True" />
      <pair e1="HPRD50.d21.s0.e1" e2="HPRD50.d21.s0.e2" id="HPRD50.d21.s0.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d21.s1" origId="12690115.2.4" text="In contrast to ____, the potency of direct activation of ___ was not affected by co-expression with ____">
      <entity charOffset="15-18" id="HPRD50.d21.s1.e0" origId="4" type="pm0111533" />
      <entity charOffset="57-59" id="HPRD50.d21.s1.e1" origId="12" type="pm0109721" />
      <entity charOffset="100-103" id="HPRD50.d21.s1.e2" origId="19" type="pm0111533" />
      <pair e1="HPRD50.d21.s1.e0" e2="HPRD50.d21.s1.e1" id="HPRD50.d21.s1.p0" interaction="False" />
      <pair e1="HPRD50.d21.s1.e0" e2="HPRD50.d21.s1.e2" id="HPRD50.d21.s1.p1" interaction="False" />
      <pair e1="HPRD50.d21.s1.e1" e2="HPRD50.d21.s1.e2" id="HPRD50.d21.s1.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d21.s2" origId="12690115.2.5" text="In addition, electron microscopy experiments revealed that ___ and ____ are closely apposed at the plasma membrane level; they are close enough to form hetero-oligomers">
      <entity charOffset="59-61" id="HPRD50.d21.s2.e0" origId="9" type="pm0109721" />
      <entity charOffset="67-70" id="HPRD50.d21.s2.e1" origId="11" type="pm0111533" />
      <pair e1="HPRD50.d21.s2.e0" e2="HPRD50.d21.s2.e1" id="HPRD50.d21.s2.p0" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d22" origId="12819203">
    <sentence id="HPRD50.d22.s0" origId="12819203.1.1" text="______, a Rho family _________________________ that interacts with signaling adapters ____ and ____">
      <entity charOffset="0-5" id="HPRD50.d22.s0.e0" origId="1" type="pm0122639" />
      <entity charOffset="21-45" id="HPRD50.d22.s0.e1" origId="7" type="pm0112603" />
      <entity charOffset="86-89" id="HPRD50.d22.s0.e2" origId="13" type="pm0112697" />
      <entity charOffset="95-98" id="HPRD50.d22.s0.e3" origId="15" type="pm0111574" />
      <pair e1="HPRD50.d22.s0.e0" e2="HPRD50.d22.s0.e1" id="HPRD50.d22.s0.p0" interaction="False" />
      <pair e1="HPRD50.d22.s0.e0" e2="HPRD50.d22.s0.e2" id="HPRD50.d22.s0.p1" interaction="True" />
      <pair e1="HPRD50.d22.s0.e0" e2="HPRD50.d22.s0.e3" id="HPRD50.d22.s0.p2" interaction="True" />
      <pair e1="HPRD50.d22.s0.e1" e2="HPRD50.d22.s0.e2" id="HPRD50.d22.s0.p3" interaction="True" />
      <pair e1="HPRD50.d22.s0.e1" e2="HPRD50.d22.s0.e3" id="HPRD50.d22.s0.p4" interaction="True" />
      <pair e1="HPRD50.d22.s0.e2" e2="HPRD50.d22.s0.e3" id="HPRD50.d22.s0.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d22.s1" origId="12819203.2.1" text="____ and ____ are scaffolding proteins acting downstream of cell surface receptors and interact with a variety of cytoplasmic signaling proteins such as ____, _____, _____________________________, Shc, and Crk">
      <entity charOffset="0-3" id="HPRD50.d22.s1.e0" origId="1" type="pm0112697" />
      <entity charOffset="9-12" id="HPRD50.d22.s1.e1" origId="3" type="pm0111574" />
      <entity charOffset="153-156" id="HPRD50.d22.s1.e2" origId="24" type="pm0105419" />
      <entity charOffset="159-163" id="HPRD50.d22.s1.e3" origId="26" type="pm0122382" />
      <entity charOffset="166-194" id="HPRD50.d22.s1.e4" origId="29" type="pm0104655||pm0110290||pm0120114||pm0122783||pm0124741" />
      <pair e1="HPRD50.d22.s1.e0" e2="HPRD50.d22.s1.e1" id="HPRD50.d22.s1.p0" interaction="False" />
      <pair e1="HPRD50.d22.s1.e0" e2="HPRD50.d22.s1.e2" id="HPRD50.d22.s1.p1" interaction="True" />
      <pair e1="HPRD50.d22.s1.e0" e2="HPRD50.d22.s1.e3" id="HPRD50.d22.s1.p2" interaction="True" />
      <pair e1="HPRD50.d22.s1.e0" e2="HPRD50.d22.s1.e4" id="HPRD50.d22.s1.p3" interaction="True" />
      <pair e1="HPRD50.d22.s1.e1" e2="HPRD50.d22.s1.e2" id="HPRD50.d22.s1.p4" interaction="True" />
      <pair e1="HPRD50.d22.s1.e1" e2="HPRD50.d22.s1.e3" id="HPRD50.d22.s1.p5" interaction="True" />
      <pair e1="HPRD50.d22.s1.e1" e2="HPRD50.d22.s1.e4" id="HPRD50.d22.s1.p6" interaction="True" />
      <pair e1="HPRD50.d22.s1.e2" e2="HPRD50.d22.s1.e3" id="HPRD50.d22.s1.p7" interaction="False" />
      <pair e1="HPRD50.d22.s1.e2" e2="HPRD50.d22.s1.e4" id="HPRD50.d22.s1.p8" interaction="False" />
      <pair e1="HPRD50.d22.s1.e3" e2="HPRD50.d22.s1.e4" id="HPRD50.d22.s1.p9" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d22.s2" origId="12819203.2.10" text="In addition, ______ contains several classic proline-rich motifs, and it interacts with the first SH3 domain of Crk and full-length ___ in vitro">
      <entity charOffset="13-18" id="HPRD50.d22.s2.e0" origId="4" type="pm0122639" />
      <entity charOffset="132-134" id="HPRD50.d22.s2.e1" origId="23" type="pm0121922" />
      <pair e1="HPRD50.d22.s2.e0" e2="HPRD50.d22.s2.e1" id="HPRD50.d22.s2.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d22.s3" origId="12819203.2.11" text="We propose that ____ and ____ in cooperation with other adapter molecules might regulate the cellular localization of ______ under specific stimuli, acting to regulate precisely Rac and _____ activities">
      <entity charOffset="16-19" id="HPRD50.d22.s3.e0" origId="4" type="pm0112697" />
      <entity charOffset="25-28" id="HPRD50.d22.s3.e1" origId="6" type="pm0111574" />
      <entity charOffset="118-123" id="HPRD50.d22.s3.e2" origId="19" type="pm0122639" />
      <entity charOffset="186-190" id="HPRD50.d22.s3.e3" origId="30" type="pm0110789" />
      <pair e1="HPRD50.d22.s3.e0" e2="HPRD50.d22.s3.e1" id="HPRD50.d22.s3.p0" interaction="False" />
      <pair e1="HPRD50.d22.s3.e0" e2="HPRD50.d22.s3.e2" id="HPRD50.d22.s3.p1" interaction="True" />
      <pair e1="HPRD50.d22.s3.e0" e2="HPRD50.d22.s3.e3" id="HPRD50.d22.s3.p2" interaction="True" />
      <pair e1="HPRD50.d22.s3.e1" e2="HPRD50.d22.s3.e2" id="HPRD50.d22.s3.p3" interaction="True" />
      <pair e1="HPRD50.d22.s3.e1" e2="HPRD50.d22.s3.e3" id="HPRD50.d22.s3.p4" interaction="True" />
      <pair e1="HPRD50.d22.s3.e2" e2="HPRD50.d22.s3.e3" id="HPRD50.d22.s3.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d22.s4" origId="12819203.2.3" text="This work led to identification of a novel _________________________ (___) for Rho family GTPases">
      <entity charOffset="43-67" id="HPRD50.d22.s4.e0" origId="10" type="pm0112603" />
      <entity charOffset="70-72" id="HPRD50.d22.s4.e1" origId="12" type="pm0112603||pm0113293" />
      <pair e1="HPRD50.d22.s4.e0" e2="HPRD50.d22.s4.e1" id="HPRD50.d22.s4.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d22.s5" origId="12819203.2.4" text="The GAP domain shows high similarity to the recently cloned _____ and displays activity toward RhoA, ____, and _____ in vitro">
      <entity charOffset="60-64" id="HPRD50.d22.s5.e0" origId="11" type="pm0102116" />
      <entity charOffset="101-104" id="HPRD50.d22.s5.e1" origId="18" type="pm0109115" />
      <entity charOffset="111-115" id="HPRD50.d22.s5.e2" origId="21" type="pm0110789" />
      <pair e1="HPRD50.d22.s5.e0" e2="HPRD50.d22.s5.e1" id="HPRD50.d22.s5.p0" interaction="False" />
      <pair e1="HPRD50.d22.s5.e0" e2="HPRD50.d22.s5.e2" id="HPRD50.d22.s5.p1" interaction="False" />
      <pair e1="HPRD50.d22.s5.e1" e2="HPRD50.d22.s5.e2" id="HPRD50.d22.s5.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d22.s6" origId="12819203.2.5" text="The protein was named ______ for its ability to interact with ___ proteins and its activity toward Rac and _____">
      <entity charOffset="22-27" id="HPRD50.d22.s6.e0" origId="5" type="pm0122639" />
      <entity charOffset="62-64" id="HPRD50.d22.s6.e1" origId="12" type="pm0100534" />
      <entity charOffset="107-111" id="HPRD50.d22.s6.e2" origId="20" type="pm0110789" />
      <pair e1="HPRD50.d22.s6.e0" e2="HPRD50.d22.s6.e1" id="HPRD50.d22.s6.p0" interaction="True" />
      <pair e1="HPRD50.d22.s6.e0" e2="HPRD50.d22.s6.e2" id="HPRD50.d22.s6.p1" interaction="True" />
      <pair e1="HPRD50.d22.s6.e1" e2="HPRD50.d22.s6.e2" id="HPRD50.d22.s6.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d22.s7" origId="12819203.2.8" text="Expression of ______ in 293T cells led to a reduction in active ____ and _____ levels but not RhoA">
      <entity charOffset="14-19" id="HPRD50.d22.s7.e0" origId="3" type="pm0122639" />
      <entity charOffset="64-67" id="HPRD50.d22.s7.e1" origId="13" type="pm0109115" />
      <entity charOffset="73-77" id="HPRD50.d22.s7.e2" origId="15" type="pm0110789" />
      <pair e1="HPRD50.d22.s7.e0" e2="HPRD50.d22.s7.e1" id="HPRD50.d22.s7.p0" interaction="True" />
      <pair e1="HPRD50.d22.s7.e0" e2="HPRD50.d22.s7.e2" id="HPRD50.d22.s7.p1" interaction="True" />
      <pair e1="HPRD50.d22.s7.e1" e2="HPRD50.d22.s7.e2" id="HPRD50.d22.s7.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d23" origId="12852857">
    <sentence id="HPRD50.d23.s0" origId="12852857.1.1" text="A role for ____ phosphorylation of ____ in cytokinesis">
      <entity charOffset="11-14" id="HPRD50.d23.s0.e0" origId="4" type="pm0109061" />
      <entity charOffset="35-38" id="HPRD50.d23.s0.e1" origId="7" type="pm0116104" />
      <pair e1="HPRD50.d23.s0.e0" e2="HPRD50.d23.s0.e1" id="HPRD50.d23.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d23.s1" origId="12852857.2.3" text="Here, we characterize the interaction between ____ and ____, show that ____ phosphorylates ____ at conserved S274 and S326 residues in vitro, and present evidence that ____ is also a substrate for ____ in vivo">
      <entity charOffset="46-49" id="HPRD50.d23.s1.e0" origId="8" type="pm0109061" />
      <entity charOffset="55-58" id="HPRD50.d23.s1.e1" origId="10" type="pm0116104" />
      <entity charOffset="71-74" id="HPRD50.d23.s1.e2" origId="14" type="pm0109061" />
      <entity charOffset="91-94" id="HPRD50.d23.s1.e3" origId="16" type="pm0116104" />
      <entity charOffset="168-171" id="HPRD50.d23.s1.e4" origId="30" type="pm0116104" />
      <entity charOffset="197-200" id="HPRD50.d23.s1.e5" origId="36" type="pm0109061" />
      <pair e1="HPRD50.d23.s1.e0" e2="HPRD50.d23.s1.e1" id="HPRD50.d23.s1.p0" interaction="True" />
      <pair e1="HPRD50.d23.s1.e0" e2="HPRD50.d23.s1.e2" id="HPRD50.d23.s1.p1" interaction="False" />
      <pair e1="HPRD50.d23.s1.e0" e2="HPRD50.d23.s1.e3" id="HPRD50.d23.s1.p2" interaction="False" />
      <pair e1="HPRD50.d23.s1.e0" e2="HPRD50.d23.s1.e4" id="HPRD50.d23.s1.p3" interaction="False" />
      <pair e1="HPRD50.d23.s1.e0" e2="HPRD50.d23.s1.e5" id="HPRD50.d23.s1.p4" interaction="False" />
      <pair e1="HPRD50.d23.s1.e1" e2="HPRD50.d23.s1.e2" id="HPRD50.d23.s1.p5" interaction="False" />
      <pair e1="HPRD50.d23.s1.e1" e2="HPRD50.d23.s1.e3" id="HPRD50.d23.s1.p6" interaction="False" />
      <pair e1="HPRD50.d23.s1.e1" e2="HPRD50.d23.s1.e4" id="HPRD50.d23.s1.p7" interaction="False" />
      <pair e1="HPRD50.d23.s1.e1" e2="HPRD50.d23.s1.e5" id="HPRD50.d23.s1.p8" interaction="False" />
      <pair e1="HPRD50.d23.s1.e2" e2="HPRD50.d23.s1.e3" id="HPRD50.d23.s1.p9" interaction="True" />
      <pair e1="HPRD50.d23.s1.e2" e2="HPRD50.d23.s1.e4" id="HPRD50.d23.s1.p10" interaction="False" />
      <pair e1="HPRD50.d23.s1.e2" e2="HPRD50.d23.s1.e5" id="HPRD50.d23.s1.p11" interaction="False" />
      <pair e1="HPRD50.d23.s1.e3" e2="HPRD50.d23.s1.e4" id="HPRD50.d23.s1.p12" interaction="False" />
      <pair e1="HPRD50.d23.s1.e3" e2="HPRD50.d23.s1.e5" id="HPRD50.d23.s1.p13" interaction="False" />
      <pair e1="HPRD50.d23.s1.e4" e2="HPRD50.d23.s1.e5" id="HPRD50.d23.s1.p14" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d23.s2" origId="12852857.2.4" text="Downregulation of ____ by RNA interference results in multiple mitotic defects, including multinucleation and cells arrested at the midbody stage, which are rescued by ectopic expression of wild-type ____, but not by ____ with mutations in the ____ phosphorylation sites">
      <entity charOffset="18-21" id="HPRD50.d23.s2.e0" origId="3" type="pm0116104" />
      <entity charOffset="200-203" id="HPRD50.d23.s2.e1" origId="31" type="pm0116104" />
      <entity charOffset="217-220" id="HPRD50.d23.s2.e2" origId="36" type="pm0116104" />
      <entity charOffset="244-247" id="HPRD50.d23.s2.e3" origId="41" type="pm0109061" />
      <pair e1="HPRD50.d23.s2.e0" e2="HPRD50.d23.s2.e1" id="HPRD50.d23.s2.p0" interaction="False" />
      <pair e1="HPRD50.d23.s2.e0" e2="HPRD50.d23.s2.e2" id="HPRD50.d23.s2.p1" interaction="False" />
      <pair e1="HPRD50.d23.s2.e0" e2="HPRD50.d23.s2.e3" id="HPRD50.d23.s2.p2" interaction="False" />
      <pair e1="HPRD50.d23.s2.e1" e2="HPRD50.d23.s2.e2" id="HPRD50.d23.s2.p3" interaction="False" />
      <pair e1="HPRD50.d23.s2.e1" e2="HPRD50.d23.s2.e3" id="HPRD50.d23.s2.p4" interaction="False" />
      <pair e1="HPRD50.d23.s2.e2" e2="HPRD50.d23.s2.e3" id="HPRD50.d23.s2.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d23.s3" origId="12852857.2.5" text="These results suggest that ____ phosphorylation of ____ may influence cytokinesis">
      <entity charOffset="27-30" id="HPRD50.d23.s3.e0" origId="5" type="pm0109061" />
      <entity charOffset="51-54" id="HPRD50.d23.s3.e1" origId="8" type="pm0116104" />
      <pair e1="HPRD50.d23.s3.e0" e2="HPRD50.d23.s3.e1" id="HPRD50.d23.s3.p0" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d24" origId="12947119">
    <sentence id="HPRD50.d24.s0" origId="12947119.1.1" text="Specific interaction of ____ and c/EBPbeta leads to the transcriptional activation of the human ________________________________ gene">
      <entity charOffset="24-27" id="HPRD50.d24.s0.e0" origId="4" type="pm0115655" />
      <entity charOffset="96-127" id="HPRD50.d24.s0.e1" origId="20" type="pm0125757" />
      <pair e1="HPRD50.d24.s0.e0" e2="HPRD50.d24.s0.e1" id="HPRD50.d24.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d24.s1" origId="12947119.2.1" text="The sterol-independent regulatory element (SIRE) of the ____________ (____) promoter mediates ____________ (OM)-induced transcription of the ____ gene through a cholesterol-independent pathway">
      <entity charOffset="56-67" id="HPRD50.d24.s1.e0" origId="11" type="pm0125757" />
      <entity charOffset="70-73" id="HPRD50.d24.s1.e1" origId="13" type="pm0125757" />
      <entity charOffset="94-105" id="HPRD50.d24.s1.e2" origId="18" type="pm0100359" />
      <entity charOffset="141-144" id="HPRD50.d24.s1.e3" origId="26" type="pm0125757" />
      <pair e1="HPRD50.d24.s1.e0" e2="HPRD50.d24.s1.e1" id="HPRD50.d24.s1.p0" interaction="False" />
      <pair e1="HPRD50.d24.s1.e0" e2="HPRD50.d24.s1.e2" id="HPRD50.d24.s1.p1" interaction="True" />
      <pair e1="HPRD50.d24.s1.e0" e2="HPRD50.d24.s1.e3" id="HPRD50.d24.s1.p2" interaction="False" />
      <pair e1="HPRD50.d24.s1.e1" e2="HPRD50.d24.s1.e2" id="HPRD50.d24.s1.p3" interaction="True" />
      <pair e1="HPRD50.d24.s1.e1" e2="HPRD50.d24.s1.e3" id="HPRD50.d24.s1.p4" interaction="False" />
      <pair e1="HPRD50.d24.s1.e2" e2="HPRD50.d24.s1.e3" id="HPRD50.d24.s1.p5" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d25" origId="12949936">
    <sentence id="HPRD50.d25.s0" origId="12949936.1.1" text="___ orphan receptor functions as negative modulator for _________________ in prostate cancer cells ____">
      <entity charOffset="0-2" id="HPRD50.d25.s0.e0" origId="1" type="pm0104071||pm0107975||pm0108440||pm0116348||pm0122716" />
      <entity charOffset="56-72" id="HPRD50.d25.s0.e1" origId="10" type="pm0125088" />
      <entity charOffset="99-102" id="HPRD50.d25.s0.e2" origId="15" type="pm0107379||pm0107715||pm0114827" />
      <pair e1="HPRD50.d25.s0.e0" e2="HPRD50.d25.s0.e1" id="HPRD50.d25.s0.p0" interaction="True" />
      <pair e1="HPRD50.d25.s0.e0" e2="HPRD50.d25.s0.e2" id="HPRD50.d25.s0.p1" interaction="False" />
      <pair e1="HPRD50.d25.s0.e1" e2="HPRD50.d25.s0.e2" id="HPRD50.d25.s0.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d25.s1" origId="12949936.2.1" text="BACKGROUND: Both _________________ (AR) and orphan receptor ___ (___) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines">
      <entity charOffset="17-33" id="HPRD50.d25.s1.e0" origId="5" type="pm0125088" />
      <entity charOffset="60-62" id="HPRD50.d25.s1.e1" origId="12" type="pm0104071||pm0107975||pm0108440||pm0116348||pm0122716" />
      <entity charOffset="65-67" id="HPRD50.d25.s1.e2" origId="14" type="pm0104071||pm0107975||pm0108440||pm0116348||pm0122716" />
      <pair e1="HPRD50.d25.s1.e0" e2="HPRD50.d25.s1.e1" id="HPRD50.d25.s1.p0" interaction="False" />
      <pair e1="HPRD50.d25.s1.e0" e2="HPRD50.d25.s1.e2" id="HPRD50.d25.s1.p1" interaction="False" />
      <pair e1="HPRD50.d25.s1.e1" e2="HPRD50.d25.s1.e2" id="HPRD50.d25.s1.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d25.s2" origId="12949936.2.7" text="The interaction between AR and ___ was assessed by _________________________ (___) pull-down assay and mammalian two-hybrid system assay">
      <entity charOffset="31-33" id="HPRD50.d25.s2.e0" origId="6" type="pm0104071||pm0107975||pm0108440||pm0116348||pm0122716" />
      <entity charOffset="51-75" id="HPRD50.d25.s2.e1" origId="10" type="pm0116848" />
      <entity charOffset="78-80" id="HPRD50.d25.s2.e2" origId="12" type="pm0116848" />
      <pair e1="HPRD50.d25.s2.e0" e2="HPRD50.d25.s2.e1" id="HPRD50.d25.s2.p0" interaction="False" />
      <pair e1="HPRD50.d25.s2.e0" e2="HPRD50.d25.s2.e2" id="HPRD50.d25.s2.p1" interaction="False" />
      <pair e1="HPRD50.d25.s2.e1" e2="HPRD50.d25.s2.e2" id="HPRD50.d25.s2.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d26" origId="14556007">
    <sentence id="HPRD50.d26.s0" origId="14556007.2.2" text="The protein ____ functions in a multi-subunit E3 ubiquitin ligase that targets the hypoxia-inducible transcription factor __________ for proteasomal degradation during normoxia">
      <entity charOffset="12-15" id="HPRD50.d26.s0.e0" origId="3" type="pm0104236" />
      <entity charOffset="122-131" id="HPRD50.d26.s0.e1" origId="18" type="pm0100197" />
      <pair e1="HPRD50.d26.s0.e0" e2="HPRD50.d26.s0.e1" id="HPRD50.d26.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d26.s1" origId="14556007.2.3" text="We establish that ____ binds to _____________________ (_____), a component of the 19S regulatory complex of the proteasome">
      <entity charOffset="18-21" id="HPRD50.d26.s1.e0" origId="4" type="pm0104236" />
      <entity charOffset="32-52" id="HPRD50.d26.s1.e1" origId="8" type="pm0113245" />
      <entity charOffset="55-59" id="HPRD50.d26.s1.e2" origId="10" type="pm0113245||pm0120764" />
      <pair e1="HPRD50.d26.s1.e0" e2="HPRD50.d26.s1.e1" id="HPRD50.d26.s1.p0" interaction="True" />
      <pair e1="HPRD50.d26.s1.e0" e2="HPRD50.d26.s1.e2" id="HPRD50.d26.s1.p1" interaction="True" />
      <pair e1="HPRD50.d26.s1.e1" e2="HPRD50.d26.s1.e2" id="HPRD50.d26.s1.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d26.s2" origId="14556007.2.4" text="_____ associates with the beta-domain of ____ and complexes with ____ and __________ in vivo">
      <entity charOffset="0-4" id="HPRD50.d26.s2.e0" origId="1" type="pm0113245||pm0120764" />
      <entity charOffset="41-44" id="HPRD50.d26.s2.e1" origId="7" type="pm0104236" />
      <entity charOffset="65-68" id="HPRD50.d26.s2.e2" origId="11" type="pm0104236" />
      <entity charOffset="74-83" id="HPRD50.d26.s2.e3" origId="14" type="pm0100197" />
      <pair e1="HPRD50.d26.s2.e0" e2="HPRD50.d26.s2.e1" id="HPRD50.d26.s2.p0" interaction="True" />
      <pair e1="HPRD50.d26.s2.e0" e2="HPRD50.d26.s2.e2" id="HPRD50.d26.s2.p1" interaction="True" />
      <pair e1="HPRD50.d26.s2.e0" e2="HPRD50.d26.s2.e3" id="HPRD50.d26.s2.p2" interaction="True" />
      <pair e1="HPRD50.d26.s2.e1" e2="HPRD50.d26.s2.e2" id="HPRD50.d26.s2.p3" interaction="False" />
      <pair e1="HPRD50.d26.s2.e1" e2="HPRD50.d26.s2.e3" id="HPRD50.d26.s2.p4" interaction="False" />
      <pair e1="HPRD50.d26.s2.e2" e2="HPRD50.d26.s2.e3" id="HPRD50.d26.s2.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d26.s3" origId="14556007.2.5" text="Overexpression of _____ promotes degradation of __________ in a pVHL-dependent manner that requires the ATPase domain of _____">
      <entity charOffset="18-22" id="HPRD50.d26.s3.e0" origId="3" type="pm0113245||pm0120764" />
      <entity charOffset="48-57" id="HPRD50.d26.s3.e1" origId="8" type="pm0100197" />
      <entity charOffset="121-125" id="HPRD50.d26.s3.e2" origId="19" type="pm0113245||pm0120764" />
      <pair e1="HPRD50.d26.s3.e0" e2="HPRD50.d26.s3.e1" id="HPRD50.d26.s3.p0" interaction="True" />
      <pair e1="HPRD50.d26.s3.e0" e2="HPRD50.d26.s3.e2" id="HPRD50.d26.s3.p1" interaction="False" />
      <pair e1="HPRD50.d26.s3.e1" e2="HPRD50.d26.s3.e2" id="HPRD50.d26.s3.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d26.s4" origId="14556007.2.6" text="Blockade of _____ expression by small interfering RNA (siRNA) causes prolonged degradation kinetics of __________">
      <entity charOffset="12-16" id="HPRD50.d26.s4.e0" origId="3" type="pm0113245||pm0120764" />
      <entity charOffset="103-112" id="HPRD50.d26.s4.e1" origId="18" type="pm0100197" />
      <pair e1="HPRD50.d26.s4.e0" e2="HPRD50.d26.s4.e1" id="HPRD50.d26.s4.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d26.s5" origId="14556007.2.7" text="Several distinct mutations in exon 2 of ___ disrupt binding of ____ to _____">
      <entity charOffset="40-42" id="HPRD50.d26.s5.e0" origId="8" type="pm0104236" />
      <entity charOffset="63-66" id="HPRD50.d26.s5.e1" origId="12" type="pm0104236" />
      <entity charOffset="71-75" id="HPRD50.d26.s5.e2" origId="14" type="pm0113245||pm0120764" />
      <pair e1="HPRD50.d26.s5.e0" e2="HPRD50.d26.s5.e1" id="HPRD50.d26.s5.p0" interaction="False" />
      <pair e1="HPRD50.d26.s5.e0" e2="HPRD50.d26.s5.e2" id="HPRD50.d26.s5.p1" interaction="True" />
      <pair e1="HPRD50.d26.s5.e1" e2="HPRD50.d26.s5.e2" id="HPRD50.d26.s5.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d26.s6" origId="14556007.2.8" text="A ____ mutant containing a P154L substitution coimmunoprecipitates with __________, but not _____, and does not promote degradation of __________">
      <entity charOffset="2-5" id="HPRD50.d26.s6.e0" origId="2" type="pm0104236" />
      <entity charOffset="72-81" id="HPRD50.d26.s6.e1" origId="11" type="pm0100197" />
      <entity charOffset="92-96" id="HPRD50.d26.s6.e2" origId="15" type="pm0113245||pm0120764" />
      <entity charOffset="135-144" id="HPRD50.d26.s6.e3" origId="24" type="pm0100197" />
      <pair e1="HPRD50.d26.s6.e0" e2="HPRD50.d26.s6.e1" id="HPRD50.d26.s6.p0" interaction="True" />
      <pair e1="HPRD50.d26.s6.e0" e2="HPRD50.d26.s6.e2" id="HPRD50.d26.s6.p1" interaction="False" />
      <pair e1="HPRD50.d26.s6.e0" e2="HPRD50.d26.s6.e3" id="HPRD50.d26.s6.p2" interaction="False" />
      <pair e1="HPRD50.d26.s6.e1" e2="HPRD50.d26.s6.e2" id="HPRD50.d26.s6.p3" interaction="False" />
      <pair e1="HPRD50.d26.s6.e1" e2="HPRD50.d26.s6.e3" id="HPRD50.d26.s6.p4" interaction="False" />
      <pair e1="HPRD50.d26.s6.e2" e2="HPRD50.d26.s6.e3" id="HPRD50.d26.s6.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d26.s7" origId="14556007.2.9" text="Thus, the ability of ____ to degrade __________ depends in part on its interaction with _____ and suggests a new mechanism for __________ stabilization in some ____-deficient tumors">
      <entity charOffset="21-24" id="HPRD50.d26.s7.e0" origId="6" type="pm0104236" />
      <entity charOffset="37-46" id="HPRD50.d26.s7.e1" origId="10" type="pm0100197" />
      <entity charOffset="88-92" id="HPRD50.d26.s7.e2" origId="18" type="pm0113245||pm0120764" />
      <entity charOffset="127-136" id="HPRD50.d26.s7.e3" origId="26" type="pm0100197" />
      <entity charOffset="160-163" id="HPRD50.d26.s7.e4" origId="30" type="pm0104236" />
      <pair e1="HPRD50.d26.s7.e0" e2="HPRD50.d26.s7.e1" id="HPRD50.d26.s7.p0" interaction="True" />
      <pair e1="HPRD50.d26.s7.e0" e2="HPRD50.d26.s7.e2" id="HPRD50.d26.s7.p1" interaction="True" />
      <pair e1="HPRD50.d26.s7.e0" e2="HPRD50.d26.s7.e3" id="HPRD50.d26.s7.p2" interaction="False" />
      <pair e1="HPRD50.d26.s7.e0" e2="HPRD50.d26.s7.e4" id="HPRD50.d26.s7.p3" interaction="False" />
      <pair e1="HPRD50.d26.s7.e1" e2="HPRD50.d26.s7.e2" id="HPRD50.d26.s7.p4" interaction="False" />
      <pair e1="HPRD50.d26.s7.e1" e2="HPRD50.d26.s7.e3" id="HPRD50.d26.s7.p5" interaction="False" />
      <pair e1="HPRD50.d26.s7.e1" e2="HPRD50.d26.s7.e4" id="HPRD50.d26.s7.p6" interaction="False" />
      <pair e1="HPRD50.d26.s7.e2" e2="HPRD50.d26.s7.e3" id="HPRD50.d26.s7.p7" interaction="False" />
      <pair e1="HPRD50.d26.s7.e2" e2="HPRD50.d26.s7.e4" id="HPRD50.d26.s7.p8" interaction="False" />
      <pair e1="HPRD50.d26.s7.e3" e2="HPRD50.d26.s7.e4" id="HPRD50.d26.s7.p9" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d27" origId="14578391">
    <sentence id="HPRD50.d27.s0" origId="14578391.1.1" text="_____/___/memA interacts with _____, ______ and SRrp130 in corneal epithelial cells">
      <entity charOffset="0-4" id="HPRD50.d27.s0.e0" origId="1" type="pm0118763" />
      <entity charOffset="6-8" id="HPRD50.d27.s0.e1" origId="3" type="pm0118763" />
      <entity charOffset="30-34" id="HPRD50.d27.s0.e2" origId="8" type="pm0111657" />
      <entity charOffset="37-42" id="HPRD50.d27.s0.e3" origId="10" type="pm0117461" />
      <pair e1="HPRD50.d27.s0.e0" e2="HPRD50.d27.s0.e1" id="HPRD50.d27.s0.p0" interaction="False" />
      <pair e1="HPRD50.d27.s0.e0" e2="HPRD50.d27.s0.e2" id="HPRD50.d27.s0.p1" interaction="True" />
      <pair e1="HPRD50.d27.s0.e0" e2="HPRD50.d27.s0.e3" id="HPRD50.d27.s0.p2" interaction="True" />
      <pair e1="HPRD50.d27.s0.e1" e2="HPRD50.d27.s0.e2" id="HPRD50.d27.s0.p3" interaction="True" />
      <pair e1="HPRD50.d27.s0.e1" e2="HPRD50.d27.s0.e3" id="HPRD50.d27.s0.p4" interaction="True" />
      <pair e1="HPRD50.d27.s0.e2" e2="HPRD50.d27.s0.e3" id="HPRD50.d27.s0.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d27.s1" origId="14578391.2.8" text="Three SR-rich proteins were identified that interact with the C-terminus of Pnn: _____ and ______, known components of spliceosome machinery, and a novel 130-kDa nuclear protein, SRrp130">
      <entity charOffset="81-85" id="HPRD50.d27.s1.e0" origId="14" type="pm0111657" />
      <entity charOffset="91-96" id="HPRD50.d27.s1.e1" origId="16" type="pm0117461" />
      <pair e1="HPRD50.d27.s1.e0" e2="HPRD50.d27.s1.e1" id="HPRD50.d27.s1.p0" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d29" origId="14752048">
    <sentence id="HPRD50.d29.s0" origId="14752048.1.1" text="Modification of de novo DNA methyltransferase 3a (______) by ______ modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription">
      <entity charOffset="50-55" id="HPRD50.d29.s0.e0" origId="9" type="pm0106301" />
      <entity charOffset="61-66" id="HPRD50.d29.s0.e1" origId="12" type="pm0108344" />
      <pair e1="HPRD50.d29.s0.e0" e2="HPRD50.d29.s0.e1" id="HPRD50.d29.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d29.s1" origId="14752048.2.3" text="Here we show that ______ interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme ____ and the E3 sumo ligases _____ and __________, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, ______, to its target proteins">
      <entity charOffset="18-23" id="HPRD50.d29.s1.e0" origId="5" type="pm0106301" />
      <entity charOffset="128-131" id="HPRD50.d29.s1.e1" origId="21" type="pm0110323" />
      <entity charOffset="157-161" id="HPRD50.d29.s1.e2" origId="27" type="pm0117395" />
      <entity charOffset="167-176" id="HPRD50.d29.s1.e3" origId="29" type="pm0119764" />
      <entity charOffset="267-272" id="HPRD50.d29.s1.e4" origId="44" type="pm0108344" />
      <pair e1="HPRD50.d29.s1.e0" e2="HPRD50.d29.s1.e1" id="HPRD50.d29.s1.p0" interaction="True" />
      <pair e1="HPRD50.d29.s1.e0" e2="HPRD50.d29.s1.e2" id="HPRD50.d29.s1.p1" interaction="True" />
      <pair e1="HPRD50.d29.s1.e0" e2="HPRD50.d29.s1.e3" id="HPRD50.d29.s1.p2" interaction="True" />
      <pair e1="HPRD50.d29.s1.e0" e2="HPRD50.d29.s1.e4" id="HPRD50.d29.s1.p3" interaction="False" />
      <pair e1="HPRD50.d29.s1.e1" e2="HPRD50.d29.s1.e2" id="HPRD50.d29.s1.p4" interaction="False" />
      <pair e1="HPRD50.d29.s1.e1" e2="HPRD50.d29.s1.e3" id="HPRD50.d29.s1.p5" interaction="False" />
      <pair e1="HPRD50.d29.s1.e1" e2="HPRD50.d29.s1.e4" id="HPRD50.d29.s1.p6" interaction="True" />
      <pair e1="HPRD50.d29.s1.e2" e2="HPRD50.d29.s1.e3" id="HPRD50.d29.s1.p7" interaction="False" />
      <pair e1="HPRD50.d29.s1.e2" e2="HPRD50.d29.s1.e4" id="HPRD50.d29.s1.p8" interaction="True" />
      <pair e1="HPRD50.d29.s1.e3" e2="HPRD50.d29.s1.e4" id="HPRD50.d29.s1.p9" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d29.s2" origId="14752048.2.4" text="______ is modified by ______ in vivo and in vitro and the region of ______ responsible for interaction maps to the N-terminal regulatory domain">
      <entity charOffset="0-5" id="HPRD50.d29.s2.e0" origId="1" type="pm0106301" />
      <entity charOffset="22-27" id="HPRD50.d29.s2.e1" origId="5" type="pm0108344" />
      <entity charOffset="68-73" id="HPRD50.d29.s2.e2" origId="15" type="pm0106301" />
      <pair e1="HPRD50.d29.s2.e0" e2="HPRD50.d29.s2.e1" id="HPRD50.d29.s2.p0" interaction="True" />
      <pair e1="HPRD50.d29.s2.e0" e2="HPRD50.d29.s2.e2" id="HPRD50.d29.s2.p1" interaction="False" />
      <pair e1="HPRD50.d29.s2.e1" e2="HPRD50.d29.s2.e2" id="HPRD50.d29.s2.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d29.s3" origId="14752048.2.5" text="Functionally, sumoylation of ______ disrupts its ability to interact with histone deacetylases (_____/2), but not with another interaction partner, ______">
      <entity charOffset="29-34" id="HPRD50.d29.s3.e0" origId="5" type="pm0106301" />
      <entity charOffset="96-100" id="HPRD50.d29.s3.e1" origId="15" type="pm0119729" />
      <entity charOffset="148-153" id="HPRD50.d29.s3.e2" origId="27" type="pm0126533" />
      <pair e1="HPRD50.d29.s3.e0" e2="HPRD50.d29.s3.e1" id="HPRD50.d29.s3.p0" interaction="True" />
      <pair e1="HPRD50.d29.s3.e0" e2="HPRD50.d29.s3.e2" id="HPRD50.d29.s3.p1" interaction="False" />
      <pair e1="HPRD50.d29.s3.e1" e2="HPRD50.d29.s3.e2" id="HPRD50.d29.s3.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d30" origId="7629131">
    <sentence id="HPRD50.d30.s0" origId="7629131.2.1" text="The tyrosine kinase _____ is physically associated with the Type I interferon (___) receptor complex and is rapidly activated during _________ stimulation">
      <entity charOffset="20-24" id="HPRD50.d30.s0.e0" origId="4" type="pm0101504" />
      <entity charOffset="79-81" id="HPRD50.d30.s0.e1" origId="14" type="pm0111853" />
      <entity charOffset="133-141" id="HPRD50.d30.s0.e2" origId="24" type="pm0111853" />
      <pair e1="HPRD50.d30.s0.e0" e2="HPRD50.d30.s0.e1" id="HPRD50.d30.s0.p0" interaction="True" />
      <pair e1="HPRD50.d30.s0.e0" e2="HPRD50.d30.s0.e2" id="HPRD50.d30.s0.p1" interaction="True" />
      <pair e1="HPRD50.d30.s0.e1" e2="HPRD50.d30.s0.e2" id="HPRD50.d30.s0.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d31" origId="7744247">
    <sentence id="HPRD50.d31.s0" origId="7744247.1.1" text="____ interaction with _____ phosphatase ties mitogenic signal transduction to cell cycle activation">
      <entity charOffset="0-3" id="HPRD50.d31.s0.e0" origId="1" type="pm0117803" />
      <entity charOffset="22-26" id="HPRD50.d31.s0.e1" origId="4" type="pm0106635||pm0109000" />
      <pair e1="HPRD50.d31.s0.e0" e2="HPRD50.d31.s0.e1" id="HPRD50.d31.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d31.s1" origId="7744247.2.3" text="We show here that _____ phosphatase associates with ____ in somatic mammalian cells and in meiotic frog oocytes">
      <entity charOffset="18-22" id="HPRD50.d31.s1.e0" origId="5" type="pm0106635||pm0109000" />
      <entity charOffset="52-55" id="HPRD50.d31.s1.e1" origId="9" type="pm0117803" />
      <pair e1="HPRD50.d31.s1.e0" e2="HPRD50.d31.s1.e1" id="HPRD50.d31.s1.p0" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d32" origId="7793988">
    <sentence id="HPRD50.d32.s0" origId="7793988.1.1" text="Differential binding of vascular cell-derived proteoglycans (________, ________, _______, and ________) to the beta-amyloid protein of Alzheimer&apos;s disease">
      <entity charOffset="61-68" id="HPRD50.d32.s0.e0" origId="8" type="pm0116983" />
      <entity charOffset="71-78" id="HPRD50.d32.s0.e1" origId="10" type="pm0124379" />
      <entity charOffset="81-87" id="HPRD50.d32.s0.e2" origId="12" type="pm0108608" />
      <entity charOffset="94-101" id="HPRD50.d32.s0.e3" origId="15" type="pm0106611" />
      <pair e1="HPRD50.d32.s0.e0" e2="HPRD50.d32.s0.e1" id="HPRD50.d32.s0.p0" interaction="False" />
      <pair e1="HPRD50.d32.s0.e0" e2="HPRD50.d32.s0.e2" id="HPRD50.d32.s0.p1" interaction="False" />
      <pair e1="HPRD50.d32.s0.e0" e2="HPRD50.d32.s0.e3" id="HPRD50.d32.s0.p2" interaction="False" />
      <pair e1="HPRD50.d32.s0.e1" e2="HPRD50.d32.s0.e2" id="HPRD50.d32.s0.p3" interaction="False" />
      <pair e1="HPRD50.d32.s0.e1" e2="HPRD50.d32.s0.e3" id="HPRD50.d32.s0.p4" interaction="False" />
      <pair e1="HPRD50.d32.s0.e2" e2="HPRD50.d32.s0.e3" id="HPRD50.d32.s0.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d32.s1" origId="7793988.2.1" text="Previous studies have demonstrated the immunolocalization of ________, a specific ____________________________, to the ____________ protein (A beta)-containing _______ deposits within the walls of blood vessels (i.e., congophilic angiopathy) in Alzheimer&apos;s disease (AD) brain">
      <entity charOffset="61-68" id="HPRD50.d32.s1.e0" origId="8" type="pm0116983" />
      <entity charOffset="82-109" id="HPRD50.d32.s1.e1" origId="14" type="pm0112250" />
      <entity charOffset="119-130" id="HPRD50.d32.s1.e2" origId="18" type="beta-pm0104696" />
      <entity charOffset="160-166" id="HPRD50.d32.s1.e3" origId="25" type="pm0104696" />
      <pair e1="HPRD50.d32.s1.e0" e2="HPRD50.d32.s1.e1" id="HPRD50.d32.s1.p0" interaction="False" />
      <pair e1="HPRD50.d32.s1.e0" e2="HPRD50.d32.s1.e2" id="HPRD50.d32.s1.p1" interaction="True" />
      <pair e1="HPRD50.d32.s1.e0" e2="HPRD50.d32.s1.e3" id="HPRD50.d32.s1.p2" interaction="True" />
      <pair e1="HPRD50.d32.s1.e1" e2="HPRD50.d32.s1.e2" id="HPRD50.d32.s1.p3" interaction="True" />
      <pair e1="HPRD50.d32.s1.e1" e2="HPRD50.d32.s1.e3" id="HPRD50.d32.s1.p4" interaction="True" />
      <pair e1="HPRD50.d32.s1.e2" e2="HPRD50.d32.s1.e3" id="HPRD50.d32.s1.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d32.s2" origId="7793988.2.10" text="Overall, the results indicate that specific vascular cell-derived ___ differentially interact with A beta, and that the interactions of highest affinity occur between A beta and binding sites on both the core protein and glycosaminoglycan chains of ________">
      <entity charOffset="66-68" id="HPRD50.d32.s2.e0" origId="10" type="pm0108066" />
      <entity charOffset="249-256" id="HPRD50.d32.s2.e1" origId="40" type="pm0116983" />
      <pair e1="HPRD50.d32.s2.e0" e2="HPRD50.d32.s2.e1" id="HPRD50.d32.s2.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d32.s3" origId="7793988.2.2" text="In the present investigation, the differential binding of previously characterized endothelial cell (EC)- and smooth muscle cell (___)-derived ___ to A beta was examined to determine whether the accumulation of A beta in cerebrovascular _______ deposits may be due to its interactions with ________">
      <entity charOffset="130-132" id="HPRD50.d32.s3.e0" origId="23" type="pm0101876" />
      <entity charOffset="143-145" id="HPRD50.d32.s3.e1" origId="26" type="pm0108066" />
      <entity charOffset="237-243" id="HPRD50.d32.s3.e2" origId="42" type="pm0104696" />
      <entity charOffset="290-297" id="HPRD50.d32.s3.e3" origId="51" type="pm0116983" />
      <pair e1="HPRD50.d32.s3.e0" e2="HPRD50.d32.s3.e1" id="HPRD50.d32.s3.p0" interaction="False" />
      <pair e1="HPRD50.d32.s3.e0" e2="HPRD50.d32.s3.e2" id="HPRD50.d32.s3.p1" interaction="False" />
      <pair e1="HPRD50.d32.s3.e0" e2="HPRD50.d32.s3.e3" id="HPRD50.d32.s3.p2" interaction="False" />
      <pair e1="HPRD50.d32.s3.e1" e2="HPRD50.d32.s3.e2" id="HPRD50.d32.s3.p3" interaction="False" />
      <pair e1="HPRD50.d32.s3.e1" e2="HPRD50.d32.s3.e3" id="HPRD50.d32.s3.p4" interaction="False" />
      <pair e1="HPRD50.d32.s3.e2" e2="HPRD50.d32.s3.e3" id="HPRD50.d32.s3.p5" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d32.s4" origId="7793988.2.3" text="Pretreatment of AA amyloidotic splenic and liver tissue sections with synthetic A beta (1-28) produced strong immunoreactivity with A beta antibodies at tissue sites enriched in ________ which was partially removed by pretreatment with heparitinase, but not by chondroitin ___ lyase">
      <entity charOffset="178-185" id="HPRD50.d32.s4.e0" origId="29" type="pm0116983" />
      <entity charOffset="273-275" id="HPRD50.d32.s4.e1" origId="43" type="pm0102466" />
      <pair e1="HPRD50.d32.s4.e0" e2="HPRD50.d32.s4.e1" id="HPRD50.d32.s4.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d32.s5" origId="7793988.2.4" text="[35S]-Sulfate labeled proteoglycans (___) derived from cultured ECs and SMCs bound to affinity columns containing A beta (1-28) or (1-40), with virtually no binding to A beta (40-1) (reverse peptide), beta-amyloid precursor protein (410-429), or bovine _____________">
      <entity charOffset="37-39" id="HPRD50.d32.s5.e0" origId="8" type="pm0108066" />
      <entity charOffset="253-265" id="HPRD50.d32.s5.e1" origId="56" type="pm0103143" />
      <pair e1="HPRD50.d32.s5.e0" e2="HPRD50.d32.s5.e1" id="HPRD50.d32.s5.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d32.s6" origId="7793988.2.5" text="Characterization of EC and ___ ___ bound to A beta (1-28) revealed strong binding by ________, weak binding by _______ and ________, two dermatan sulfate proteoglycans, and lack of binding by ________/____, a large chondroitin sulfate proteoglycan">
      <entity charOffset="27-29" id="HPRD50.d32.s6.e0" origId="5" type="pm0101876" />
      <entity charOffset="31-33" id="HPRD50.d32.s6.e1" origId="6" type="pm0108066" />
      <entity charOffset="85-92" id="HPRD50.d32.s6.e2" origId="18" type="pm0116983" />
      <entity charOffset="111-117" id="HPRD50.d32.s6.e3" origId="23" type="pm0108608" />
      <entity charOffset="123-130" id="HPRD50.d32.s6.e4" origId="25" type="pm0124379" />
      <entity charOffset="192-199" id="HPRD50.d32.s6.e5" origId="37" type="pm0106611" />
      <entity charOffset="201-204" id="HPRD50.d32.s6.e6" origId="39" type="pm0106611" />
      <pair e1="HPRD50.d32.s6.e0" e2="HPRD50.d32.s6.e1" id="HPRD50.d32.s6.p0" interaction="False" />
      <pair e1="HPRD50.d32.s6.e0" e2="HPRD50.d32.s6.e2" id="HPRD50.d32.s6.p1" interaction="False" />
      <pair e1="HPRD50.d32.s6.e0" e2="HPRD50.d32.s6.e3" id="HPRD50.d32.s6.p2" interaction="False" />
      <pair e1="HPRD50.d32.s6.e0" e2="HPRD50.d32.s6.e4" id="HPRD50.d32.s6.p3" interaction="False" />
      <pair e1="HPRD50.d32.s6.e0" e2="HPRD50.d32.s6.e5" id="HPRD50.d32.s6.p4" interaction="False" />
      <pair e1="HPRD50.d32.s6.e0" e2="HPRD50.d32.s6.e6" id="HPRD50.d32.s6.p5" interaction="False" />
      <pair e1="HPRD50.d32.s6.e1" e2="HPRD50.d32.s6.e2" id="HPRD50.d32.s6.p6" interaction="True" />
      <pair e1="HPRD50.d32.s6.e1" e2="HPRD50.d32.s6.e3" id="HPRD50.d32.s6.p7" interaction="True" />
      <pair e1="HPRD50.d32.s6.e1" e2="HPRD50.d32.s6.e4" id="HPRD50.d32.s6.p8" interaction="True" />
      <pair e1="HPRD50.d32.s6.e1" e2="HPRD50.d32.s6.e5" id="HPRD50.d32.s6.p9" interaction="False" />
      <pair e1="HPRD50.d32.s6.e1" e2="HPRD50.d32.s6.e6" id="HPRD50.d32.s6.p10" interaction="False" />
      <pair e1="HPRD50.d32.s6.e2" e2="HPRD50.d32.s6.e3" id="HPRD50.d32.s6.p11" interaction="False" />
      <pair e1="HPRD50.d32.s6.e2" e2="HPRD50.d32.s6.e4" id="HPRD50.d32.s6.p12" interaction="False" />
      <pair e1="HPRD50.d32.s6.e2" e2="HPRD50.d32.s6.e5" id="HPRD50.d32.s6.p13" interaction="False" />
      <pair e1="HPRD50.d32.s6.e2" e2="HPRD50.d32.s6.e6" id="HPRD50.d32.s6.p14" interaction="False" />
      <pair e1="HPRD50.d32.s6.e3" e2="HPRD50.d32.s6.e4" id="HPRD50.d32.s6.p15" interaction="False" />
      <pair e1="HPRD50.d32.s6.e3" e2="HPRD50.d32.s6.e5" id="HPRD50.d32.s6.p16" interaction="False" />
      <pair e1="HPRD50.d32.s6.e3" e2="HPRD50.d32.s6.e6" id="HPRD50.d32.s6.p17" interaction="False" />
      <pair e1="HPRD50.d32.s6.e4" e2="HPRD50.d32.s6.e5" id="HPRD50.d32.s6.p18" interaction="False" />
      <pair e1="HPRD50.d32.s6.e4" e2="HPRD50.d32.s6.e6" id="HPRD50.d32.s6.p19" interaction="False" />
      <pair e1="HPRD50.d32.s6.e5" e2="HPRD50.d32.s6.e6" id="HPRD50.d32.s6.p20" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d33" origId="7963560">
    <sentence id="HPRD50.d33.s0" origId="7963560.2.5" text="Cross-linking of ____ with the use of the mAb MEM-53 and a polyclonal sheep anti-mouse Ig promoted activation of resting B cells into the G1 phase of the cell cycle as judged by increased expression of the early activation Ag ____, increases in cellular volume, RNA synthesis, and _____ protein levels, and enhanced binding of 7-aminoactinomycin D">
      <entity charOffset="17-20" id="HPRD50.d33.s0.e0" origId="3" type="pm0107494" />
      <entity charOffset="226-229" id="HPRD50.d33.s0.e1" origId="41" type="pm0115739" />
      <entity charOffset="281-285" id="HPRD50.d33.s0.e2" origId="52" type="pm0104123" />
      <pair e1="HPRD50.d33.s0.e0" e2="HPRD50.d33.s0.e1" id="HPRD50.d33.s0.p0" interaction="True" />
      <pair e1="HPRD50.d33.s0.e0" e2="HPRD50.d33.s0.e2" id="HPRD50.d33.s0.p1" interaction="True" />
      <pair e1="HPRD50.d33.s0.e1" e2="HPRD50.d33.s0.e2" id="HPRD50.d33.s0.p2" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d33.s1" origId="7963560.2.8" text="However, cytokines, in particular ____ and ____, potentiated the DNA synthesis induced by cross-linking of ____">
      <entity charOffset="34-37" id="HPRD50.d33.s1.e0" origId="7" type="pm0110478" />
      <entity charOffset="43-46" id="HPRD50.d33.s1.e1" origId="9" type="pm0106845" />
      <entity charOffset="107-110" id="HPRD50.d33.s1.e2" origId="19" type="pm0107494" />
      <pair e1="HPRD50.d33.s1.e0" e2="HPRD50.d33.s1.e1" id="HPRD50.d33.s1.p0" interaction="False" />
      <pair e1="HPRD50.d33.s1.e0" e2="HPRD50.d33.s1.e2" id="HPRD50.d33.s1.p1" interaction="True" />
      <pair e1="HPRD50.d33.s1.e1" e2="HPRD50.d33.s1.e2" id="HPRD50.d33.s1.p2" interaction="True" />
    </sentence>
  </document>
  <document id="HPRD50.d34" origId="8078915">
    <sentence id="HPRD50.d34.s0" origId="8078915.2.11" text="The human ____ mRNA editing protein is a __________________ showing structural homology to some known mammalian and bacteriophage deoxycytidylate deaminases">
      <entity charOffset="10-13" id="HPRD50.d34.s0.e0" origId="3" type="pm0126272" />
      <entity charOffset="41-58" id="HPRD50.d34.s0.e1" origId="10" type="pm0107865" />
      <pair e1="HPRD50.d34.s0.e0" e2="HPRD50.d34.s0.e1" id="HPRD50.d34.s0.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d34.s1" origId="8078915.2.13" text="The fact that the ____ mRNA editing protein also exists as a _________ has important implications for the mechanism of ____ mRNA editing in humans">
      <entity charOffset="18-21" id="HPRD50.d34.s1.e0" origId="5" type="pm0126272" />
      <entity charOffset="61-69" id="HPRD50.d34.s1.e1" origId="13" type="pm0125626" />
      <entity charOffset="119-122" id="HPRD50.d34.s1.e2" origId="21" type="pm0126272" />
      <pair e1="HPRD50.d34.s1.e0" e2="HPRD50.d34.s1.e1" id="HPRD50.d34.s1.p0" interaction="False" />
      <pair e1="HPRD50.d34.s1.e0" e2="HPRD50.d34.s1.e2" id="HPRD50.d34.s1.p1" interaction="False" />
      <pair e1="HPRD50.d34.s1.e1" e2="HPRD50.d34.s1.e2" id="HPRD50.d34.s1.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d35" origId="8617498">
    <sentence id="HPRD50.d35.s0" origId="8617498.1.1" text="Assignment of _____, ____, and Etfa to chromosomes 3, 7, and 13: the mouse homologs of genes responsible for glutaric acidemia type II in human">
      <entity charOffset="14-18" id="HPRD50.d35.s0.e0" origId="3" type="pm0103481" />
      <entity charOffset="21-24" id="HPRD50.d35.s0.e1" origId="5" type="pm0110405" />
      <pair e1="HPRD50.d35.s0.e0" e2="HPRD50.d35.s0.e1" id="HPRD50.d35.s0.p0" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d35.s1" origId="8617498.2.4" text="We used cDNA probes for the _____, ____, and Etfa genes to determine localization of these mouse genes to chromosomes 3, 7, and 13">
      <entity charOffset="28-32" id="HPRD50.d35.s1.e0" origId="7" type="pm0103481" />
      <entity charOffset="35-38" id="HPRD50.d35.s1.e1" origId="9" type="pm0110405" />
      <pair e1="HPRD50.d35.s1.e0" e2="HPRD50.d35.s1.e1" id="HPRD50.d35.s1.p0" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d38" origId="8999895">
    <sentence id="HPRD50.d38.s0" origId="8999895.2.6" text="Subsequent amino acid sequencing revealed many peptides involving __________ cross-linked either to itself or to a variety of other known CE protein components, including ______________, ___________, ______, keratins, members of the small proline-rich superfamily, ________, and unknown proteins related to the ___________ family">
      <entity charOffset="66-75" id="HPRD50.d38.s0.e0" origId="9" type="pm0104308" />
      <entity charOffset="171-184" id="HPRD50.d38.s0.e1" origId="27" type="pm0104526" />
      <entity charOffset="187-197" id="HPRD50.d38.s0.e2" origId="29" type="pm0110549" />
      <entity charOffset="200-205" id="HPRD50.d38.s0.e3" origId="31" type="pm0114270" />
      <entity charOffset="265-272" id="HPRD50.d38.s0.e4" origId="42" type="pm0103809" />
      <entity charOffset="311-321" id="HPRD50.d38.s0.e5" origId="50" type="pm0110549" />
      <pair e1="HPRD50.d38.s0.e0" e2="HPRD50.d38.s0.e1" id="HPRD50.d38.s0.p0" interaction="True" />
      <pair e1="HPRD50.d38.s0.e0" e2="HPRD50.d38.s0.e2" id="HPRD50.d38.s0.p1" interaction="True" />
      <pair e1="HPRD50.d38.s0.e0" e2="HPRD50.d38.s0.e3" id="HPRD50.d38.s0.p2" interaction="True" />
      <pair e1="HPRD50.d38.s0.e0" e2="HPRD50.d38.s0.e4" id="HPRD50.d38.s0.p3" interaction="True" />
      <pair e1="HPRD50.d38.s0.e0" e2="HPRD50.d38.s0.e5" id="HPRD50.d38.s0.p4" interaction="True" />
      <pair e1="HPRD50.d38.s0.e1" e2="HPRD50.d38.s0.e2" id="HPRD50.d38.s0.p5" interaction="False" />
      <pair e1="HPRD50.d38.s0.e1" e2="HPRD50.d38.s0.e3" id="HPRD50.d38.s0.p6" interaction="False" />
      <pair e1="HPRD50.d38.s0.e1" e2="HPRD50.d38.s0.e4" id="HPRD50.d38.s0.p7" interaction="False" />
      <pair e1="HPRD50.d38.s0.e1" e2="HPRD50.d38.s0.e5" id="HPRD50.d38.s0.p8" interaction="False" />
      <pair e1="HPRD50.d38.s0.e2" e2="HPRD50.d38.s0.e3" id="HPRD50.d38.s0.p9" interaction="False" />
      <pair e1="HPRD50.d38.s0.e2" e2="HPRD50.d38.s0.e4" id="HPRD50.d38.s0.p10" interaction="False" />
      <pair e1="HPRD50.d38.s0.e2" e2="HPRD50.d38.s0.e5" id="HPRD50.d38.s0.p11" interaction="False" />
      <pair e1="HPRD50.d38.s0.e3" e2="HPRD50.d38.s0.e4" id="HPRD50.d38.s0.p12" interaction="False" />
      <pair e1="HPRD50.d38.s0.e3" e2="HPRD50.d38.s0.e5" id="HPRD50.d38.s0.p13" interaction="False" />
      <pair e1="HPRD50.d38.s0.e4" e2="HPRD50.d38.s0.e5" id="HPRD50.d38.s0.p14" interaction="False" />
    </sentence>
    <sentence id="HPRD50.d38.s1" origId="8999895.2.7" text="Specific glutamines or lysines of __________ were used to cross-link the different proteins, such as glutamines 495 and 496 to ___________, glutamine 288 to keratins, and lysines 468, 485, and 508 and glutamines 465 and 489 for interchain __________ cross-links">
      <entity charOffset="34-43" id="HPRD50.d38.s1.e0" origId="6" type="pm0104308" />
      <entity charOffset="127-137" id="HPRD50.d38.s1.e1" origId="22" type="pm0110549" />
      <entity charOffset="239-248" id="HPRD50.d38.s1.e2" origId="44" type="pm0104308" />
      <pair e1="HPRD50.d38.s1.e0" e2="HPRD50.d38.s1.e1" id="HPRD50.d38.s1.p0" interaction="False" />
      <pair e1="HPRD50.d38.s1.e0" e2="HPRD50.d38.s1.e2" id="HPRD50.d38.s1.p1" interaction="False" />
      <pair e1="HPRD50.d38.s1.e1" e2="HPRD50.d38.s1.e2" id="HPRD50.d38.s1.p2" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d39" origId="9153302">
    <sentence id="HPRD50.d39.s0" origId="9153302.2.4" text="A prominent isolate, designated _____/______, specifically interacts with the ___ not only in vivo but also in vitro">
      <entity charOffset="32-36" id="HPRD50.d39.s0.e0" origId="6" type="pm0120029" />
      <entity charOffset="38-43" id="HPRD50.d39.s0.e1" origId="8" type="pm0122990" />
      <entity charOffset="78-80" id="HPRD50.d39.s0.e2" origId="14" type="pm0113359" />
      <pair e1="HPRD50.d39.s0.e0" e2="HPRD50.d39.s0.e1" id="HPRD50.d39.s0.p0" interaction="False" />
      <pair e1="HPRD50.d39.s0.e0" e2="HPRD50.d39.s0.e2" id="HPRD50.d39.s0.p1" interaction="True" />
      <pair e1="HPRD50.d39.s0.e1" e2="HPRD50.d39.s0.e2" id="HPRD50.d39.s0.p2" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d39.s1" origId="9153302.2.7" text="_____ is a nuclear protein with a characteristic distribution in large irregularly shaped nuclear speckles and co-localizes perfectly with the SR domain-containing ____________________">
      <entity charOffset="0-4" id="HPRD50.d39.s1.e0" origId="1" type="pm0120029" />
      <entity charOffset="164-183" id="HPRD50.d39.s1.e1" origId="25" type="pm0120690" />
      <pair e1="HPRD50.d39.s1.e0" e2="HPRD50.d39.s1.e1" id="HPRD50.d39.s1.p0" interaction="False" />
    </sentence>
  </document>
  <document id="HPRD50.d40" origId="9668116">
    <sentence id="HPRD50.d40.s0" origId="9668116.2.6" text="Transient expression of the full-length ____ without RSRS in U1240MG glioblastoma cells resulted in repression of _______ promoter activity">
      <entity charOffset="40-43" id="HPRD50.d40.s0.e0" origId="6" type="pm0110165" />
      <entity charOffset="114-120" id="HPRD50.d40.s0.e1" origId="17" type="pm0124654-1.B" />
      <pair e1="HPRD50.d40.s0.e0" e2="HPRD50.d40.s0.e1" id="HPRD50.d40.s0.p0" interaction="True" />
    </sentence>
    <sentence id="HPRD50.d40.s1" origId="9668116.2.9" text="These results suggest that the relative abundance of the two splice variants of ____ in brain could be an important determinant for the expression of _____">
      <entity charOffset="80-83" id="HPRD50.d40.s1.e0" origId="14" type="pm0110165" />
      <entity charOffset="150-154" id="HPRD50.d40.s1.e1" origId="26" type="pm0124654" />
      <pair e1="HPRD50.d40.s1.e0" e2="HPRD50.d40.s1.e1" id="HPRD50.d40.s1.p0" interaction="True" />
    </sentence>
  </document>
</corpus>